Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

Commission file number 000-56132

GREEN THUMB INDUSTRIES INC.

(Exact name of registrant as specified in its charter)


British Columbia	98-1437430
(State or other jurisdiction of incorporation or organization)	(I.R.S. employer identification no.)

325 West Huron Street, Suite 700 Chicago, Illinois	60654
(Address of principal executive offices)	(zip code)

Registrant’s telephone number, including area code - (312) 471-6720

Securities registered pursuant to Section 12(g) of the Act:

Subordinate Voting Shares

Multiple Voting Shares

Super Voting Shares

(Title of each Class)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐	Smaller reporting company	☐

Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of August 1, 2024 there were 211,380,808 shares of the registrant’s Subordinate Voting Shares, 37,683 shares of the registrant’s Multiple Voting Shares and 206,690 shares of the registrant’s Super Voting Shares outstanding.

GREEN THUMB INDUSTRIES INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024

TABLE OF CONTENTS


FINANCIAL INFORMATION		Page
	Part I
ITEM 1:	Unaudited Interim Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023	4
	Unaudited Interim Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023	5
	Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three and six months ended June 30, 2024 and 2023	6
	Unaudited Interim Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023	8
	Notes to Unaudited Interim Condensed Consolidated Financial Statements	10
ITEM 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
ITEM 3:	Quantitative and Qualitative Disclosure About Market Risk	35
ITEM 4:	Controls and Procedures	35

OTHER INFORMATION
ITEM 1:	Legal Proceedings	36
ITEM 1A:	Risk Factors	36
ITEM 2:	Unregistered Sales of Equity Securities and Use of Proceeds	36
ITEM 3:	Defaults Upon Senior Securities	36
ITEM 4:	Mine Safety Disclosures	37
ITEM 5:	Other Information	37
ITEM 6:	Exhibits	38
Signatures		39

Use of Names

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “we,” “us,” “our,” “Company,” “Corporation” or “Green Thumb” refer to Green Thumb Industries Inc. together with its wholly-owned subsidiaries.

Currency

Unless otherwise indicated, all references to “$” or “US$” in this document refer to United States dollars, and all references to “C$” refer to Canadian dollars.

Disclosure Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains statements that we believe are, or may be considered to be, “forward-looking statements.” All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “project,” “anticipate,” “believe,” “plan,” “forecast,” “continue” or “could” or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the “SEC”), and in press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change; state regulation of cannabis is uncertain; the Company may not be able to obtain or maintain necessary permits and authorizations; the Company may be subject to heightened scrutiny by Canadian regulatory authorities; the Company may face limitations on ownership of cannabis licenses; the Company may become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco Firearms and Explosives regulation; as a cannabis business, the Company is subject to applicable anti-money laundering laws and regulations and has restricted access to banking and other financial services; the Company may face difficulties acquiring additional financing; the Company lacks access to U.S. bankruptcy protections; the Company operates in a highly regulated sector and may not always succeed in complying fully with application regulatory requirements in all jurisdictions where the Company carries business; the Company faces intense competition; the Company faces competition from the illicit market as well as actual or purported Farm Bill compliant hemp products; the Company is dependent upon the popularity and consumer acceptance of its brand portfolio; the Company has limited trademark protection; cannabis businesses are subject to unfavorable tax treatment and may incur significant tax liability; the Company is subject to proceeds of crime statutes; the Company faces exposure to fraudulent or illegal activity; the Company faces risks due to industry immaturity or limited comparable, competitive or established industry best practices; the Company faces risks related to its products; the Company’s business is subject to the risks inherent in agricultural operations; the Company may adversely be impacted by rising or volatile energy costs and availability; the Company faces risks related to its information technology systems and potential cyber-attacks and security breaches; the Company relies on third-party software providers for numerous capabilities that it depends upon to operate, and a disruption of one or more systems could adversely affect the business; the Company relies on the expertise of the Company management team and other employees experienced in the cannabis industry, and the loss of key personnel could negatively affect the Company’s business, financial condition and results of operations; the Company faces an inherent risk of product liability or similar claims; the Company’s products may be subject to product recalls; the Company may face unfavorable publicity or consumer perception; and the Company’s voting control is concentrated; the Company’s capital structure and voting control may cause unpredictability; sales of substantial amounts of Subordinate Voting Shares by our shareholders in the public market may have an adverse effect on the market price of our Subordinate Voting Shares and could affect the Company’s business and financial condition and the results of operations. These and other risks are further described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and elsewhere in the Company’s filings with the SEC, which are available on the SEC’s website or at https://investors.gtigrows.com. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this document, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this document.

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Balance Sheets

As of June 30, 2024 and December 31, 2023

(Amounts Expressed in United States Dollars)


	June 30,			December 31,
	2024			2023
				(Audited)
	(in thousands)
ASSETS
Current Assets:
Cash and Cash Equivalents	$	196,142		$	161,634
Accounts Receivable, Net		49,335			42,975
Income Tax Receivable		3,486			—
Inventories, Net		130,530			112,970
Prepaid Expenses		19,497			19,801
Other Current Assets		4,812			5,382
Total Current Assets		403,802			342,762
Property and Equipment, Net		694,039			687,106
Right of Use Assets, Net		247,533			238,369
Investments		61,412			64,361
Investments in Associates		23,484			24,942
Note Receivable		3,550			550
Intangible Assets, Net		513,434			538,678
Goodwill		589,691			589,691
Deferred Tax Assets		1,041			1,041
Deposits and Other Assets		2,568			2,557
TOTAL ASSETS	$	2,540,554		$	2,490,057
LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES
Current Liabilities:
Accounts Payable	$	29,433		$	24,495
Accrued Liabilities		62,776			59,552
Compensation Payable		12,917			16,005
Current Portion of Notes Payable		227,265			2,996
Current Portion of Lease Liabilities		12,853			12,297
Income Tax Payable		25,335			10,705
Total Current Liabilities		370,579			126,050
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion		261,031			249,464
Notes Payable, Net of Current Portion and Debt Discount		82,478			305,527
Contingent Consideration Payable		—			33,250
Deferred Income Taxes		72,510			72,510
TOTAL LIABILITIES		786,598			786,801
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY
Subordinate Voting Shares (Shares Authorized, Issued and Outstanding at June 30, 2024: Unlimited, 211,129,419, and 211,129,419, respectively, at December 31, 2023: Unlimited, 209,871,792, and 209,871,792, respectively)		—			—
Multiple Voting Shares (Shares Authorized, Issued and Outstanding at June 30, 2024: Unlimited, 37,683 and 37,683, respectively, at December 31, 2023: Unlimited, 38,531 and 38,531, respectively)		—			—
Super Voting Shares (Shares Authorized, Issued and Outstanding at June 30, 2024: Unlimited, 206,690 and 206,690, respectively, at December 31, 2023: Unlimited, 216,690 and 216,690, respectively)		—			—
Share Capital		1,742,784			1,703,852
Contributed (Deficit) Surplus		(31,865	)		7,871
Deferred Share Issuances		12,973			12,973
Accumulated Earnings (Deficit)		29,970			(21,818	)
Equity of Green Thumb Industries Inc.		1,753,862			1,702,878
Noncontrolling interests		94			378
TOTAL SHAREHOLDERS' EQUITY		1,753,956			1,703,256
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	2,540,554		$	2,490,057

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Operations

Three and Six Months Ended June 30, 2024 and 2023

(Amounts Expressed in United States Dollars, Except Share Amounts)


		Three Months Ended June 30,								Six Months Ended June 30,
		2024				2023				2024				2023
		(in thousands)								(in thousands)
Revenues, Net of Discounts	$		280,147		$		252,388		$		555,953		$		500,924
Cost of Goods Sold			(129,627	)			(127,108	)			(260,504	)			(250,923	)
Gross Profit			150,520				125,280				295,449				250,001
Expenses:
Selling, General, and Administrative			96,500				84,217				170,758				164,736
Total Expenses			96,500				84,217				170,758				164,736
Income From Operations			54,020				41,063				124,691				85,265
Other Income (Expense):
Other Income (Expense), Net			2,464				(270	)			701				654
Interest Income, Net			2,314				1,531				4,417				3,262
Interest Expense, Net			(5,981	)			(2,869	)			(13,495	)			(6,685	)
Total Other Expense			(1,203	)			(1,608	)			(8,377	)			(2,769	)
Income Before Provision for Income Taxes And Non-Controlling Interest			52,817				39,455				116,314				82,496
Provision For Income Taxes			31,899				25,765				64,048				59,401
Net Income Before Non-Controlling Interest			20,918				13,690				52,266				23,095
Net Income Attributable to Non-Controlling Interest			206				290				478				556
Net Income Attributable To Green Thumb Industries Inc.	$		20,712		$		13,400		$		51,788		$		22,539
Net Income Per Share - Basic	$		0.09		$		0.05		$		0.22		$		0.09
Net Income Per Share - Diluted	$		0.09		$		0.05		$		0.22		$		0.09
Weighted Average Number of Shares Outstanding - Basic			237,416,373				238,000,135				237,083,912				237,700,856
Weighted average Number of Shares Outstanding - Diluted			240,137,922				238,423,288				240,768,497				239,455,964

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and Six Months Ended June 30, 2024 and 2023

(Amounts Expressed in United States Dollars)


		Share Capital			Contributed Surplus (Deficit)				Deferred Share Issuance				Accumulated Earnings (Deficit)				Non-Controlling Interest				Total
		(in thousands)
Balance, April 1, 2023	$		1,683,671	$		28,959		$		17,105		$		(48,946	)	$		357		$		1,681,146
Issuance of deferred shares			1,348			—				(1,348	)			—				—				—
Distribution of contingent consideration			6,070			—				—				—				—				6,070
Indemnification of deferred shares associated with post acquisition costs			—			—				(2,784	)			—				—				(2,784	)
Exercise of options, RSUs			2,340			(1,919	)			—				—				—				421
Stock-based compensation			—			7,381				—				—				—				7,381
Distributions to limited liability company unit holders			—			—				—				—				(108	)			(108	)
Net income			—			—				—				13,400				290				13,690
Balance, June 30, 2023	$		1,693,429	$		34,421		$		12,973		$		(35,546	)	$		539		$		1,705,816
Balance, January 1, 2023	$		1,663,557	$		23,233		$		36,211		$		(58,085	)	$		516		$		1,665,432
Issuance of deferred shares			20,454			—				(20,454	)			—				—				—
Distribution of contingent consideration			6,070			—				—				—				—				6,070
Indemnification of deferred shares associated with post acquisition costs			—			—				(2,784	)			—				—				(2,784	)
Exercise of options and RSUs			3,348			(2,432	)			—				—				—				916
Stock-based compensation			—			13,620				—				—				—				13,620
Distributions to limited liability company unit holders			—			—				—				—				(533	)			(533	)
Net income			—			—				—				22,539				556				23,095
Balance, June 30, 2023	$		1,693,429	$		34,421		$		12,973		$		(35,546	)	$		539		$		1,705,816

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements


		Share Capital		Contributed Surplus (Deficit)		Deferred Share Issuance		Accumulated Earnings (Deficit)		Non-Controlling Interest		Total
		(in thousands)
Balance, April 1, 2024	$	1,727,584	$	(2,816)	$	12,973	$	9,258	$	131	$	1,747,130
Exercise of options and RSUs		5,157		(2,527)		—		—		—		2,630
Options exercised through net share settlement		10,043		(15,498)		—		—		—		(5,455)
Stock-based compensation		—		8,866		—		—		—		8,866
Distributions to limited liability company unit holders		—		—		—		—		(243)		(243)
Repurchase of Subordinate Voting Shares		—		(19,890)		—		—		-		(19,890)
Net income		—		—		—		20,712		206		20,918
Balance, June 30, 2024	$	1,742,784	$	(31,865)	$	12,973	$	29,970	$	94	$	1,753,956
Balance, January 1, 2024	$	1,703,852	$	7,871	$	12,973	$	(21,818)	$	378	$	1,703,256
Distribution of contingent consideration		17,259		—		—		—		—		17,259
Exercise of options and RSUs		10,789		(4,851)		—		—		—		5,938
Options exercised through net share settlement		10,884		(16,793)		—		—		—		(5,909)
Stock-based compensation		—		15,356		—		—		—		15,356
Distributions to limited liability company unit holders		—		—		—		—		(762)		(762)
Repurchase of Subordinate Voting Shares		—		(33,448)		—		—		—		(33,448)
Net income		—		—		—		51,788		478		52,266
Balance, June 30, 2024	$	1,742,784	$	(31,865)	$	12,973	$	29,970	$	94	$	1,753,956

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Six Months Ended June 30, 2024 and 2023

(Amounts Expressed in United States Dollars)


	Six Months Ended June 30,
	2024			2023
	(in thousands)
CASH FLOW FROM OPERATING ACTIVITIES
Net income attributable to Green Thumb Industries Inc.	$	51,788		$	22,539
Net income attributable to non-controlling interest		478			556
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		55,760			47,735
Amortization of operating lease assets		24,676			24,368
Loss on disposal of property and equipment		875			1,951
Impairment of long-lived property and equipment		—			285
Loss on equity method investments		1,100			750
Loss from lease modification		219			—
Stock-based compensation		15,356			13,620
(Increase) decrease in fair value of investments		(334	)		928
Gain on settlement of contingent consideration		(15,991	)		—
Increase in fair value of contingent consideration		—			2,150
Decrease in fair value of warrants		(1,534	)		(2,263	)
Gain on indemnification of deferred shares associated with post acquisition costs		—			(2,784	)
Amortization of debt discount		2,853			4,762
Changes in operating assets and liabilities:
Accounts receivable, net		(6,359	)		(8,265	)
Inventories, net		(17,561	)		(9,097	)
Prepaid expenses and other current assets		874			(3,285	)
Deposits and other assets		(10	)		676
Accounts payable		4,938			9,071
Accrued liabilities		(2,164	)		3,365
Operating lease liabilities		(21,934	)		(21,589	)
Income tax receivable and payable, net		11,144			7,555
NET CASH PROVIDED BY OPERATING ACTIVITIES		104,174			93,028
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment		(34,963	)		(129,392	)
Proceeds from disposal of property and equipment		—			319
Investments in securities and associates		(5,608	)		(2,800	)
Proceeds from equity investments and notes receivable		6,248			331
NET CASH USED IN INVESTING ACTIVITIES		(34,323	)		(131,542	)
CASH FLOW FROM FINANCING ACTIVITIES
Distributions to limited liability company unit holders		(762	)		(533	)
Repurchase of Subordinate Voting Shares		(33,448	)		—
Payments for taxes related to net share settlement of equity awards		(5,438	)		—
Proceeds from exercise of options and warrants		5,938			916
Proceeds from issuance of notes payable		—			10,134
Principal repayment of notes payable		(1,633	)		(659	)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES		(35,343	)		9,858
CASH AND CASH EQUIVALENTS:
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		34,508			(28,656	)
CASH AND CASH EQUIVALENTS BEGINNING OF PERIOD		161,634			177,682
CASH AND CASH EQUIVALENTS END OF PERIOD	$	196,142		$	149,026

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Six Months Ended June 30, 2024 and 2023

(Amounts Expressed in United States Dollars)


	Six Months Ended June 30,
	2024			2023
	(in thousands)
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	$	10,975		$	10,086
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	$	3,358		$	12,630
Noncash increase in right of use asset	$	(10,333	)	$	(3,928	)
Noncash increase in lease liability	$	10,333		$	3,928
Issuance of shares associated with contingent consideration	$	17,259		$	6,070
Deferred share distributions	$	—		$	20,454

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation

(a) Description of Business

Green Thumb Industries Inc. (“Green Thumb,” the “Company,” “we” or “us”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail locations. The Company also owns and operates retail cannabis stores that include a national chain named RISE Dispensaries, and sell our products and third-party products. As of June 30, 2024, Green Thumb has revenue in fourteen markets (California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately 4,500 people and serves millions of patients and customers annually.

The Company’s registered office is located at 250 Howe Street, 20th Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters are at 325 W. Huron St., Suite 700, Chicago, IL 60654.

(b) Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP, have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.

There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2023 Form 10-K.

(d) Earnings per Share

Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of June 30, 2024, the Company had 9,196,881 options, 4,665,523 restricted stock units and 2,128,022 warrants outstanding. As of June 30, 2023, the Company had 10,874,051 options, 3,453,460 restricted stock units and 3,734,555 warrants outstanding.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation (Continued)

(d) Earnings per Share (Continued)

In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended June 30, 2024, the computation of diluted earnings per share included 1,632,323 options, 971,792 restricted stock units, and 117,434 warrants. For the six months ended June 30, 2024, the computation of diluted earnings per share included 1,625,478 options, 1,939,848 restricted stock units, and 119,259 warrants. For the three months ended June 30, 2023, the computation of diluted earnings per share included 135,894 options and 287,259 restricted stock units. For the six months ended June 30, 2023, the computation of diluted earnings per share included 167,191 options and 1,587,917 restricted stock units. There were no dilutive warrants during the three and six months ended June 30, 2023 as the strike price was greater than the average stock price for the period. For the three and six months ended June 30, 2024, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 896,810 and 978,895, respectively. For the three and six months ended June 30, 2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 3,399,518 and 3,473,866, respectively.

(e) Recently Issued Accounting Standards

(i)

In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, to provide enhanced segment disclosures. The standard will require disclosures about significant segment expense categories and amounts for each reportable segment, for all periods presented. Additionally, the standard requires public entities to disclose the title and position of the Chief Operating Decision Maker (“CODM”) in the consolidated financial statements. These enhanced disclosures are required for all entities on an interim and annual basis, effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

(ii)

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to provide enhancements to annual income tax disclosures. The standard will require more detailed information in the rate reconciliation table and for income taxes paid, among other enhancements. The standard is effective for years beginning after December 15, 2024 and early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

2. INVENTORIES

The Company’s inventories include the following at June 30, 2024 and December 31, 2023:


		June 30, 2024		December 31, 2023
		(in thousands)
Raw Material	$	2,205	$	1,547
Packaging and Miscellaneous		11,021		10,661
Work in Process		51,219		47,029
Finished Goods		70,320		57,631
Reserve for Obsolete Inventory		(4,235)		(3,898)
Total Inventories, Net	$	130,530	$	112,970

3. PROPERTY AND EQUIPMENT

At June 30, 2024 and December 31, 2023, property and equipment consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Buildings and Improvements	$	354,195	$	353,912
Equipment, Computers and Furniture		182,041		171,522
Leasehold Improvements		222,073		200,232
Land Improvements		1,168		1,046
Capitalized Interest		31,603		30,817
Total Property and Equipment		791,080		757,529
Less: Accumulated Depreciation		(157,168)		(127,290)
Property and Equipment, net		633,912		630,239
Land		33,725		33,725
Assets Under Construction		26,402		23,142
Property and Equipment, net	$	694,039	$	687,106

Assets under construction represent costs associated with construction projects on cultivation and production facilities and retail stores as well as costs associated with internal-use software not yet placed in service.

Depreciation expense for the three and six months ended June 30, 2024 totaled $15,412 thousand and $30,516 thousand, respectively, of which $9,930 thousand and $19,723 thousand, respectively, is included in cost of goods sold. Depreciation expense for the three and six months ended June 30, 2023 totaled $11,490 thousand and $22,381 thousand respectively, of which $7,694 thousand and $15,050 thousand, respectively, is included in cost of goods sold.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

4. INTANGIBLE ASSETS AND GOODWILL

(a) Intangible Assets

Intangible assets are recorded at cost less accumulated amortization and impairment losses. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

At June 30, 2024 and December 31, 2023, intangible assets consisted of the following:


		June 30, 2024						December 31, 2023
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	179,813	$	480,903	$	660,716	$	157,764	$	502,952
Trademarks		41,511		14,746		26,765		41,511		13,378		28,133
Customer Relationships		24,438		18,672		5,766		24,438		16,927		7,511
Non-Competition Agreements		2,565		2,565		—		2,565		2,483		82
Total Intangible Assets	$	729,230	$	215,796	$	513,434	$	729,230	$	190,552	$	538,678

The Company recorded amortization expense for the three and six months ended June 30, 2024 of $12,573 thousand and $25,244 thousand, respectively. The Company recorded amortization expense for the three and six months ended June 30, 2023 of $12,744 thousand and $25,354 thousand, respectively. As of June 30, 2024 and December 31, 2023, intangible assets are carried net of accumulated impairment losses of $31,131 thousand as of each period then ended.

The following table outlines the estimated annual amortization expense related to intangible assets as of June 30, 2024:


		Estimated Amortization
Year Ending December 31,		(in thousands)
Remainder of 2024	$	25,148
2025		50,294
2026		47,332
2027		46,803
2028		46,803
2029 and Thereafter		297,054
	$	513,434

As of June 30, 2024, the weighted average amortization period remaining for intangible assets was 10.91 years.

(b) Goodwill

At June 30, 2024 and December 31, 2023 the balances of goodwill, by segment, consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Retail	$	273,802	$	273,802
Consumer Packaged Goods		315,889		315,889
Total	$	589,691	$	589,691

Goodwill is recognized net of accumulated impairment losses of $57,372 thousand as of June 30, 2024 and December 31, 2023. During the three and six months ended June 30, 2024 and 2023, there were no goodwill impairment charges recognized by the Company in the unaudited interim condensed consolidated statements of operations.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

5. INVESTMENTS

As of June 30, 2024 and December 31, 2023, the Company held various equity interests in cannabis-related companies as well as investments in note(s) receivable instruments that had a combined fair value of $61,412 thousand and $64,361 thousand, respectively. The Company measures its investments that do not have readily determinable fair value at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company performs an assessment on a quarterly basis to determine whether triggering events for impairment exist and to identify any observable price changes.

The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2024 and year ended December 31, 2023:


		June 30, 2024		December 31, 2023
		(in thousands)
Beginning	$	64,361	$	74,169
Additions		2,965		8,200
Disposals		(6,248)		(498)
Fair value adjustment		334		(17,460)
Transfers and other		—		(50)
Ending	$	61,412	$	64,361

The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments recorded during the three and six months ended June 30, 2024 and 2023.


	Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
	(in thousands)
Equity Investments	$	(481)	$	(655)	$	158	$	(1,134)
Notes Receivable Instruments		9		—		9		—
Accrued Interest on Notes Receivable Instruments		84		78		167		206
Net fair value gains (losses)	$	(388)	$	(577)	$	334	$	(928)

(a) Equity Investments

As of June 30, 2024 and December 31, 2023, the Company held equity investments in publicly traded entities which have readily determinable fair values, which are classified as Level 1 investments of $507 thousand and $2,001 thousand, respectively. During the three and six months ended June 30, 2024, the Company recorded (losses) gains on the change in fair value of such investments of $(481) thousand and $158 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statement of operations. During the three and six months ended June 30, 2023, the Company recorded net losses on the change in fair value of such investments of $655 thousand and $1,134 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statement of operations. During the six months ended June 30, 2024 and 2023, the Company received proceeds from the sale of such investments of $1,652 thousand and $31 thousand, respectively.

As of June 30, 2024 and December 31, 2023, the Company held equity investments in privately held entities that did not have readily determinable fair values, which are classified as Level 3 investments, of $25,953 thousand as of each period end. For the three and six months ended June 30, 2024 and 2023, there were no gains or losses on the change in fair value of such investments. There were no sales of these investments during these periods.

These investments are classified as trading securities and are included within investments on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

5. INVESTMENTS (Continued)

(a) Equity Investments (Continued)

Unrealized (losses) gains associated with the Company's equity investments recorded during the three and six months ended June 30, 2024 were $(253) thousand and $319 thousand, respectively. Unrealized (losses) gains associated with the Company's equity investments recorded during the three and six months ended June 30, 2023 were $(653) thousand and $1,996 thousand, respectively.

(b) Notes Receivable Instruments

As of June 30, 2024 and December 31, 2023, the Company held note receivable instruments, which were classified as a Level 1 investment as they represent public debt of a publicly traded entity, and had a fair value of $24,188 thousand and $22,214 thousand, respectively. During the three and six months ended June 30, 2024, the Company recorded fair value adjustments of $9 thousand on these instruments. There were no gains (losses) recognized on these investments during the three and six months ended June 30, 2023. The notes receivable had a stated interest rate of 13% and a maturity date of April 29, 2025. The notes did not contain any conversion features.

As of June 30, 2024 and December 31, 2023, the Company held note receivable instruments, which were classified as Level 3 investments as they represent loans provided to privately held entities that do not have readily determinable fair values. The note receivable instruments had a combined fair value of $10,764 thousand and $14,193 thousand, respectively, with stated interest ranging between 2.7% - 10% and terms between twelve months to five years. The combined fair value of these notes receivable instruments includes the initial investment cost and combined contractual accrued interest of $84 thousand and $167 thousand for the three and six months ended June 30, 2024, respectively, and $78 thousand and $206 thousand for the three and six months ended June 30, 2023, respectively. The accrued interest is recorded within interest income on the unaudited interim condensed consolidated statements of operations.

On January 9, 2024, one of the Company's privately held note receivable instruments matured. As a result, the Company received the principal amount of $4,000 thousand along with the accrued interest of $605 thousand on such date.

These notes receivable instruments are classified as trading securities and are included within investments on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

6. LEASES

(a) Operating Leases

The Company has operating leases for its retail stores, processing and cultivation facilities and corporate office spaces. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date.

All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for fixed and variable non-lease components, such as taxes, insurance and maintenance. The Company accounts for each real estate lease and the related non-lease components together as a single component.

The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. For three and six months ended June 30, 2024, the Company recorded operating lease expense of $12,425 thousand and $24,676 thousand, respectively compared to operating lease expense of $12,146 thousand and $24,368 thousand for three and six months ended June 30, 2023, respectively.

Other information related to operating leases as of June 30, 2024 and December 31, 2023 were as follows:


	June 30, 2024	December 31, 2023
Weighted average remaining lease term (years)	11.19	11.75
Weighted average discount rate	12.29%	12.40%

Maturities of lease liabilities for operating leases as of June 30, 2024 were as follows:


		Maturities of Lease Liability
Year Ending December 31,		Third-Party		Related Party		Total
		(in thousands)
Remainder of 2024	$	22,626	$	292	$	22,918
2025		44,893		592		45,485
2026		45,102		603		45,705
2027		45,622		572		46,194
2028		44,898		364		45,262
2029 and Thereafter		329,894		1,364		331,258
Total Lease Payments		533,035		3,787		536,822
Less: Interest		(261,707)		(1,231)		(262,938)
Present Value of Lease Liability	$	271,328	$	2,556	$	273,884

(b) Related Party Operating Leases

The Company has leasing arrangements that are related party transactions, including for certain facilities in Maryland, Massachusetts and Nevada. Wendy Berger, a former director of the Company, is a principal of WBS Equities, LLC, which is the Manager of Mosaic Real Estate, LLC, which owned the facilities leased by the Company. Additionally, Mosaic Real Estate, LLC is owned in part by Ms. Berger (through the Wendy Berger 1998 Revocable Trust), Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (through KP Capital, LLC), and Anthony Georgiadis, the President and a director of the Company (through Three One Four Holdings, LLC). The terms of these leases range from 7 years to 15 years. For the three and six months ended June 30, 2024, the Company recorded lease expense of $166 thousand and $305 thousand, respectively, compared to lease expense of $137 thousand and $276 thousand for the three and six months ended June 30, 2023, respectively, associated with these leasing arrangements.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

7. NOTES PAYABLE

At June 30, 2024 and December 31, 2023, notes payable consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Charitable contributions1	$	48	$	351
Private placement debt dated April 30, 20212		224,435		221,680
Mortgage notes3		85,260		86,492
Total notes payable		309,743		308,523
Less: current portion of notes payable		(227,265)		(2,996)
Notes payable, net of current portion	$	82,478	$	305,527

1 In connection with acquisitions completed in 2017 and 2019, the Company committed to provide charitable contributions of $50 thousand per quarter through October 2024 and $250 thousand per year through May 2024, respectively. The net present value of these contributions has been recorded as a liability with interest rates ranging between 2.17% - 7.00%.

2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $249,934 thousand with an interest rate of 7%, maturing on April 30, 2025. The outstanding principal balance of the April 30, 2021 Notes was $224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $2,755 thousand as of December 31, 2023.

3 The Company has issued various mortgage notes at an aggregate value of $88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $671 thousand and $725 thousand, and are presented net of principal payments of $2,854 thousand and $1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00% and 7.77%.

(a) April 30, 2021 Private Placement Financing:

As of June 30, 2024, the Company reclassified the April 30, 2021 Notes to current portion of notes payable on the unaudited interim condensed consolidated balance sheets due to its approaching maturity. The Company is actively evaluating potential partners to refinance the April 30, 2021 Notes. While the exact amount of capital required for the refinancing has not yet been determined, the Company possesses the ability to fully repay the April 30, 2021 Notes if necessary. The Company remains confident in its ability to secure acceptable financing terms or utilize its cash reserves to settle the obligation.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

8. WARRANTS

As part of the terms of the Company’s issuance of the April 30, 2021 Notes, as well as other financing arrangements, the Company issued warrants, which allow the holders to purchase Subordinate Voting Shares at an exercise price determined at the time of issuance.

The following table summarizes the number of warrants outstanding as of June 30, 2024 and December 31, 2023:


	Liability Classified				Equity Classified
	Number of Shares		Weighted Average Exercise Price (C$)	Weighted Average Remaining Contractual Life	Number of Shares		Weighted Average Exercise Price (USD)	Weighted Average Remaining Contractual Life
Balance as of December 31, 2023	1,997,208	C$	18.03	0.50	1,737,347	$	31.83	2.38
Warrants Expired	(1,606,533)		—	—	—		—	—
Balance as of June 30, 2024	390,675	C$	12.42	0.46	1,737,347	$	31.83	1.88

(a) Liability Classified Warrants Outstanding

The following table summarizes the fair value of the liability classified warrants at June 30, 2024 and December 31, 2023:


				Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		June 30, 2024		December 31, 2023		Change
				(in thousands)
Private Placement Financing Warrants Issued May 2019	C$19.39	—	$	—	$	1,673	$	(1,673)
Modification Warrants Issued November 2019	C$12.04	316,947		1,280		1,151		129
Additional Modification Warrants Issued May 2020	C$14.03	73,728		303		293		10
Totals		390,675	$	1,583	$	3,117	$	(1,534)

During the three and six months ended June 30, 2024 and 2023, the Company recorded gains of $3,641 thousand and $1,534 thousand, and $621 thousand and $2,263 thousand, respectively, on the change in the fair value of the warrant liability within other income (expense) on the unaudited interim condensed consolidated statements of operations.

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 13 - Fair Value Measurements for additional details):


	June 30,	December 31,
Significant Assumptions	2024	2023
Volatility	74.81%-79.97%	61.76% - 74.31%
Remaining Term	0.36-0.89 years	0.39-1.39 years
Risk Free Rate	4.02%	3.91%

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

8. WARRANTS (Continued)

(b) Equity Classified Warrants Outstanding

The Company's equity classified warrants were recorded at fair value at each respective date of issuance. Equity classified warrants are not remeasured at fair value on a recurring basis and are carried at their issuance date fair value. The following table summarizes the carrying amounts of the Company's equity classified warrants at June 30, 2024 and December 31, 2023:


				Issuance Date Fair Value
		Warrants		June 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price	Outstanding		2024		2023
				(in thousands)
Mortgage Warrants Issued June 2020	$9.10	35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$32.68	1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$30.02	243,303		2,616		2,616
Totals		1,737,347	$	25,056	$	25,056

The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date:


Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL

Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares are classified as equity. Incremental costs directly attributable to the issuance of common shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the applicable vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes.

(a) Authorized

The Company has the following classes of share capital, with each class having no par value:

(i) Subordinate Voting Shares

The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares.

(ii) Multiple Voting Shares

Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple Voting Shares.

(iii) Super Voting Shares

Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares or one Multiple Voting Share. The Company is authorized to issue an unlimited number of Super Voting Shares.

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:


	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2024	209,871,792	38,531	216,690
Distribution of contingent consideration	1,250,000	—	—
Issuance of shares upon exercise of options	843,387	—	—
Issuances of shares upon vesting of RSUs	804,440	—	—
Repurchase of Subordinate Voting Shares	(2,725,000)	—	—
Exchange of shares	1,084,800	(848)	(10,000)
As at June 30, 2024	211,129,419	37,683	206,690

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL (Continued)

(i) Distribution of Contingent Consideration

Dharma Pharmaceuticals, LLC

In connection with the Company's 2021 acquisition of Dharma Pharmaceuticals, LLC (“Dharma”), the purchase agreement included contingent consideration of up to $65,000 thousand in Subordinate Voting Shares of Green Thumb, dependent upon 1) the successful opening of five retail stores in the Virginia area within the first three years following the signing of the agreement (“Retail Stores Milestone”) and 2) the legal sale of adult-use cannabis in a retail store on or before January 1, 2025 (the “Recreational Sales Milestone”). The Retail Stores Milestone was fully achieved prior to expiration and settled in previous periods.

On February 9, 2024, the Company and the former owners of Dharma agreed to amend the conditions of the Recreational Sales Milestone (the “Amended Agreement”). Under the Amended Agreement, the former owners waived their right to the Recreational Sales Milestone in exchange for the delivery of 1,250,000 Subordinate Voting Shares. On February 15, 2024, the Company recorded a gain of $15,991 thousand, representing the settlement of the Recreational Sales Milestone and distributed the shares to the former owners of Dharma, which had a fair market value of $17,259 thousand, which was based on the value of the shares as traded on the Canadian Securities Exchange on the date of distribution. The gain was recorded within sales general and administrative expenses on the unaudited interim condensed consolidated statement of operations.

(ii) Repurchase of Subordinate Voting Shares

On September 5, 2023, the Company's Board of Directors authorized the repurchase of up to 5%, or 10,486,951 of its Subordinate Voting Shares over a 12-month period at an aggregate cost of up to $50,000 thousand. On February 28, 2024, the Company's Board of Directors authorized an increase in its share repurchase program of $50,000 thousand. During the six months ended June 30, 2024, the Company repurchased 2,725,000 Subordinate Voting Shares at an average price of $12.27 per share, bringing the total remaining repurchase ability to approximately $26,700 thousand through September 10, 2024.

The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity.

In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1 and Amendment No. 2 thereto (as amended, the “Plan”). The maximum number of Restricted Stock Units (“RSUs”) and options outstanding under the Plan at any time shall not exceed 10% of the then issued and outstanding shares on an as-converted basis.

The Company recognizes compensation expense for RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized.

Option and RSU awards generally vest over three years, and options typically have a life of five to ten years. Option grants under the Plan are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL (Continued)

Stock option activity is summarized as follows:


	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life
Balance as of December 31, 2023	10,071,467	$11.75	4.31
Granted	797,289	14.96
Exercised	(843,387)	8.81
Forfeited	(828,488)	14.06
Balance as of June 30, 2024	9,196,881	$12.44	4.41
Exercisable as of June 30, 2024	4,214,462	$8.00	3.78

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the six months ended June 30, 2024 and the year ended December 31, 2023, using the following ranges of assumptions:


	June 30,	December 31,
	2024	2023
Risk-free interest rate	3.25% - 3.92%	3.06% - 4.32%
Expected dividend yield	0%	0%
Expected volatility	62% - 64%	64%
Expected option life	4.46 - 4.5 years	3.5 – 4.5 years

As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.

The following table summarizes the number of unvested RSU awards as of June 30, 2024 and December 31, 2023 and the changes during the six months ended June 30, 2024:


	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2023	3,620,638	$	9.25
Granted	2,458,964		14.75
Forfeited	(609,639)		11.29
Vested	(804,440)		9.89
Unvested Shares at June 30, 2024	4,665,523	$	11.88

The stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was as follows:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Stock options expense	$	2,637	$	4,303	$	5,694	$	8,786
Restricted Stock Units		6,229		3,078		9,662		4,834
Total Stock Based Compensation Expense	$	8,866	$	7,381	$	15,356	$	13,620

As of June 30, 2024, $63,591 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.21 years.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

10. INCOME TAX EXPENSE

The following table summarizes the Company’s income tax expense and effective tax rates for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
Income before Income Taxes	$	52,817	$	39,455	$	116,314	$	82,496
Income Tax Expense		31,899		25,765		64,048		59,401
Effective Tax Rate		60.4%		65.3%		55.1%		72.0%

The effective tax rates for the three months ended June 30, 2024 and 2023 were based on the Company’s forecasted annualized effective tax rates and were adjusted for discrete items that occurred within the periods presented.

Due to its cannabis operations, the Company is subject to the limitations of the U.S. Internal Revenue Code of 1986, as amended (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income and provides for effective tax rates that are well in excess of statutory tax rates.

Taxes paid during the six months ended June 30, 2024 and 2023 were $52,904 thousand and $52,134 thousand, respectively.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

11. OTHER INCOME (EXPENSE)

For the three and six months ended June 30, 2024 and 2023 other income (expense) was comprised of the following:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	(472)	$	(655)	$	167	$	(1,134)
Fair value adjustments on warrants issued		3,641		621		1,534		2,263
Loss from equity method investments		(772)		(432)		(1,100)		(750)
Other		67		196		100		275
Total Other Income (Expense)	$	2,464	$	(270)	$	701	$	654

12. COMMITMENTS AND CONTINGENCIES

The Company is subject to lawsuits, investigations and other claims related to employment, commercial and other matters that arise out of operations in the normal course of business. Periodically, the Company reviews the status of each significant matter and assesses the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably estimated, such amount is recognized in other liabilities.

Contingent liabilities are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period and are discounted to present value where the effect is material. The Company performs evaluations to identify contingent liabilities for contracts. Contingent consideration is measured upon acquisition and is estimated using probability weighting of potential payouts. Subsequent changes in the estimated contingent consideration from the final purchase price allocation are recognized in the Company’s unaudited interim condensed consolidated statements of operations.

(a) Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, sanctions, restrictions on its operations, or losses of permits that could result in the Company ceasing operations in that specific state or local jurisdiction. The Company may be subject to regulatory fines, penalties, or restrictions in the future as cannabis and other regulations continue to evolve and are subject to differing interpretations.

(b) Claims and Litigation

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. Subsequent to June 30, 2024, the Company received Findings of Fact and Conclusions of Law from an October 30, 2019 complaint filed against Green Thumb (“Defendant”) alleging Defendant breached a commercial property lease with ineffective termination. The court ruled in favor of Plaintiff in the amount of $7,307 thousand, representing unpaid rent. In addition, the court found Defendant liable for attorney fees, which have yet to be determined. As of June 30, 2024, the Company accrued the amount of probable loss that can reasonably be estimated within accrued liabilities on the unaudited interim condensed consolidated balance sheets. No final Order of Judgment has been entered in the case and the Company has reserved all rights and intends to contest the findings, including an appeal if necessary.

Other than the matter discussed above, as of June 30, 2024 and December 31, 2023, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s consolidated operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest.

As of June 30, 2024, the Company held approximately $5,400 thousand of open construction commitments to contractors on work being performed.

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

13. FAIR VALUE MEASUREMENTS

The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3 – Inputs for the asset or liability that are not based on observable market data.

(a) Financial Instruments

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, investments, accounts payable and accrued liabilities, notes payable, warrant liability, and contingent consideration payable.

It was not practicable to estimate the fair value of the Company's long-term notes payable, which consist of charitable contributions, private placement debt and mortgage notes, since there were no quoted market prices or active trading markets. The carrying amount of notes payable at June 30, 2024 and December 31, 2023 was $309,743 thousand and $308,523 thousand, respectively, which includes $227,265 thousand and $2,996 thousand, respectively, of short-term debt due within one year.

Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements. The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:


		As of June 30, 2024
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	196,142	$	—	$	—	$	196,142
Investments		24,695		—		36,717		61,412
Warrant Liability		—		—		(1,583)		(1,583)
	$	220,837	$	—	$	35,134	$	255,971


		As of December 31, 2023
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	161,634	$	—	$	—	$	161,634
Investments		24,215		—		40,146		64,361
Contingent Consideration Payable		—		—		(33,250)		(33,250)
Warrant Liability		—		—		(3,117)		(3,117)
	$	185,849	$	—	$	3,779	$	189,628

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

14. SEGMENT REPORTING

The Company operates in two segments: the cultivation, production and sale of cannabis products to retail stores (“Consumer Packaged Goods”) and retailing of cannabis to patients and consumers (“Retail”). The Company does not allocate operating expenses to these business units, nor does it allocate specific assets. Additionally, the CODM does not review total assets or net income (loss) by segments; therefore, such information is not presented below.

The below table presents revenues by type for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	204,656	$	188,044	$	408,434	$	376,922
Consumer Packaged Goods		156,323		136,054		306,235		261,671
Intersegment Eliminations		(80,832)		(71,710)		(158,716)		(137,669)
Total Revenues, Net of Discounts	$	280,147	$	252,388	$	555,953	$	500,924
Depreciation and Amortization
Retail	$	10,436	$	9,109	$	20,683	$	17,941
Consumer Packaged Goods		17,549		15,125		35,077		29,794
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	27,985	$	24,234	$	55,760	$	47,735
Income Taxes
Retail	$	16,405	$	13,328	$	33,969	$	32,339
Consumer Packaged Goods		15,494		12,437		30,079		27,062
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	31,899	$	25,765	$	64,048	$	59,401

Goodwill assigned to the Retail segment as of June 30, 2024 and December 31, 2023 was $273,802 thousand, respectively. Intangible assets, net assigned to the Retail segment as of June 30, 2024 and December 31, 2023 was $266,423 thousand and $278,492 thousand, respectively.

Goodwill assigned to the Consumer Packaged Goods segment as of June 30, 2024 and December 31, 2023 was $315,889 thousand, respectively. Intangible assets, net assigned to the Consumer Packaged Goods segment as of June 30, 2024 and December 31, 2023 was $247,011 thousand and $260,186 thousand, respectively.

The Company’s assets are aggregated into two reportable segments (Retail and Consumer Packaged Goods). For the purposes of testing goodwill, Green Thumb has identified two reporting units which align with our reportable segments (Retail and Consumer Packaged Goods). All revenues are derived from customers domiciled in the United States and all assets are located in the United States.

ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Green Thumb Industries Inc. (the “Company” or “Green Thumb”) is for the three and six months ended June 30, 2024 and 2023. It is supplemental to, and should be read in conjunction with, the Company’s unaudited interim condensed consolidated financial statements as of June 30, 2024 and the consolidated financial statements for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the U.S. Securities and Exchange Commission (“SEC”) on February 29, 2024 (the “2023 Form 10-K”) and the accompanying notes for each respective period. The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Financial information presented in this MD&A is presented in United States dollars (“$” or “US$”), unless otherwise indicated.

This MD&A contains certain “forward-looking statements” and certain “forward-looking information” as defined under applicable United States securities laws. Please refer to the discussion of forward-looking statements and information set out under the heading “Disclosure Regarding Forward-Looking Statements,” identified in the ‘‘Risks and Uncertainties’’ section of this MD&A and in Part I, Item 1A, “Risk Factors of the 2023 Form 10-K.” As a result of many factors, the Company’s actual results may differ materially from those anticipated in these forward-looking statements and information.

OVERVIEW OF THE COMPANY

Established in 2014 and headquartered in Chicago, Illinois, Green Thumb, a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. As of June 30, 2024, Green Thumb has operations in fourteen U.S. markets, employs approximately 4,500 people and serves millions of patients and customers annually.

Green Thumb’s core business is manufacturing, distributing and marketing a portfolio of cannabis consumer packaged goods brands (which we refer to as our Consumer Packaged Goods business), including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RYTHM. The Company distributes and markets these products primarily to third-party licensed retail cannabis stores across the United States as well as to Green Thumb-owned retail stores (which we refer to as our Retail business).

The Company’s Consumer Packaged Goods portfolio is primarily generated from plant material that Green Thumb grows and processes itself, which we use to produce our consumer packaged goods in twenty manufacturing facilities. This portfolio consists of cannabis product categories, including flower, pre-rolls, concentrates, vape, capsules, tinctures, edibles, topicals, as well as other cannabis-related products across a range of stock keeping units ("SKUs") (none of which product categories are individually material to the Company).

Green Thumb owns and operates a national cannabis retail chain called RISE Dispensaries that provides relationship-centric retail experiences aimed to deliver a superior level of customer service through high-engagement consumer interaction, a consultative, transparent and education-forward selling approach and a consistently available assortment of cannabis products. In addition, Green Thumb owns Retail stores under other names, primarily where naming is subject to licensing or similar restrictions. The income from Green Thumb’s Retail business is primarily derived from the sale of cannabis-related products, which includes the sale of Green Thumb produced products as well as those produced by third parties, with an immaterial (under 10%) portion of this income resulting from the sale of other merchandise (such as t-shirts and accessories for cannabis use). The RISE Dispensaries currently are located in fourteen of the states in which we operate. As of June 30, 2024, the Company had 94 open and operating Retail locations. The Company’s new store opening plans will remain fluid depending on market conditions, obtaining local licensing, construction and other permissions and subject to the Company’s capital allocation plans.

Results of Operations – Consolidated

The following table sets forth the Company’s selected consolidated financial results for the periods, and as of the dates, indicated. The (i) unaudited interim condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 and (ii) unaudited interim condensed consolidated balance sheets as of June 30, 2024 and December 31, 2023 have been derived from, and should be read in conjunction with, the unaudited interim condensed consolidated financial statements and accompanying notes presented in Item 1 of this quarterly report on Form 10-Q.

The Company’s unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on a going-concern basis that contemplates continuity of operations and realization of assets and liquidation of liabilities in the ordinary course of business.


		Three Months Ended June 30,				Six Months Ended June 30,				QTD Change			YTD Change
		2024		2023		2024		2023		$	%		$	%
		(in thousands, except share and per share amounts)								Increase (Decrease)
Revenues, Net of Discounts	$	280,147	$	252,388	$	555,953	$	500,924	$	27,759	11%	$	55,029	11%
Cost of Goods Sold		(129,627)		(127,108)		(260,504)		(250,923)		2,519	2%		9,581	4%
Gross Profit		150,520		125,280		295,449		250,001		25,240	20%		45,448	18%
Expenses:
Selling, General, and Administrative		96,500		84,217		170,758		164,736		12,283	15%		6,022	4%
Total Expenses		96,500		84,217		170,758		164,736		12,283	15%		6,022	4%
Income From Operations		54,020		41,063		124,691		85,265		12,957	32%		39,426	46%
Total Other Expense		(1,203)		(1,608)		(8,377)		(2,769)		(405)	(25)%		(5,608)	203%
Income Before Provision for Income Taxes And Non-Controlling Interest		52,817		39,455		116,314		82,496		13,362	34%		33,818	41%
Provision for Income Taxes		31,899		25,765		64,048		59,401		6,134	24%		4,647	8%
Net Income Before Non-Controlling Interest		20,918		13,690		52,266		23,095		7,228	53%		29,171	126%
Net Income Attributable to Non-Controlling Interest		206		290		478		556		(84)	(29)%		(78)	(14)%
Net Income Attributable To Green Thumb Industries Inc.	$	20,712	$	13,400	$	51,788	$	22,539	$	7,312	55%	$	29,249	130%
Net Income Per Share - Basic	$	0.09	$	0.05	$	0.22	$	0.09	$	0.04	80%	$	0.13	144%
Net Income Per Share - Diluted	$	0.09	$	0.05	$	0.22	$	0.09	$	0.04	80%	$	0.13	144%
Weighted Average Number of Shares Outstanding – Basic		237,416,373		238,000,135		237,083,912		237,700,856
Weighted Average Number of Shares Outstanding – Diluted		240,137,922		238,423,288		240,768,497		239,455,964


		June 30, 2024		December 31, 2023
		(in thousands)
Total Assets	$	2,540,554	$	2,490,057
Long-Term Liabilities	$	416,019	$	660,751

Three Months Ended June 30, 2024 Compared to the Three Months Ended June 30, 2023

Revenues, net of Discounts

Revenues, net of discounts for the three months ended June 30, 2024 was $280,147 thousand, up 11% from $252,388 thousand for the three months ended June 30, 2023. Key performance drivers for the period included (i) the legalization of adult-use sales in Maryland, which began on July 1, 2023, and (ii) revenue generated from new retail stores.

The Company generated revenue from 94 Retail stores during the quarter compared to 83 in the same quarter of the prior year. Retail revenues made up 73% of total revenues during the three months ended June 30, 2024 as compared to 75% during the three months ended June 30, 2023. Since June 30, 2023, the Company opened ten new Retail stores in Florida, one new Retail store in Nevada, and one new Retail store in New York. The Company also disposed of one Retail store in Massachusetts.

Consumer Packaged Goods revenues made up 27% of total revenues during the three months ended June 30, 2024 as compared to 25% during the three months ended June 30, 2023.

Cost of Goods Sold

Cost of goods sold are derived from retail purchases made by the Company from its third-party licensed producers operating within our state markets and costs related to the internal cultivation and production of cannabis. Cost of goods sold for the three months ended June 30, 2024 was $129,627 thousand, up 2% from $127,108 thousand for the three months ended June 30, 2023, driven by increased demand stemming from the launch of adult-use sales in Maryland, as well as increased sales volume at the Company's newly opened Retail locations.

Gross Profit

Gross profit for the three months ended June 30, 2024 was $150,520 thousand, representing a gross margin on the sale of branded cannabis flower and processed and packaged products including concentrates, edibles, topicals and other cannabis products, of 54%. This is compared to gross profit for the three months ended June 30, 2023 of $125,280 thousand, or a 50% gross margin. The increase in gross profit (dollars) was directly attributable to the revenue increase as described above. The increase in gross margin (percent) was primarily driven by an increase in Retail sales of Green Thumb-produced products.

Total Expenses

Total expenses for the three months ended June 30, 2024 were $96,500 thousand, or 34% of revenues, net of discounts, an increase of $12,283 thousand compared to the same period in the prior year. Total expenses for the three months ended June 30, 2023 were $84,217 thousand or 33% of revenues, net of discounts. The increase in total expenses was attributable to increased expenses associated with the launch of adult-use sales in Maryland, increased expenses associated with the opening of new Retail stores as described above, as well as an increase in payroll expenses, stemming from annual wage increases that took effect during the current quarter.

Total Other Income (Expense)

Total other income (expense) for the three months ended June 30, 2024 was $(1,203) thousand, a favorable change of $(405) thousand, primarily due to a favorable fair value adjustments on the Company's warrant liability during the three months ended June 30, 2024, as compared to the three months ended June 30, 2023, and offset by a decrease in capitalized interest for the three months ended June 30, 2024, as compared to the three months ended June 30, 2023.

Income Before Provision for Income Taxes and Non-Controlling Interest

Income before provision for income taxes and non-controlling interest for the three months ended June 30, 2024 was $52,817 thousand, an increase of $13,362 thousand compared to the three months ended June 30, 2023.

As presented under the heading “Non-GAAP Measures” below, after adjusting for non-cash equity incentive compensation of $8,866 thousand and $7,381 thousand in the three months ended June 30, 2024 and 2023, respectively, and other nonoperating expenses of $2,925 thousand and $3,138 thousand in three months ended June 30, 2024 and 2023, respectively, adjusted earnings before interest, depreciation, and amortization (“Adjusted EBITDA”) was $93,796 thousand and $75,816 thousand, respectively.

Provision for Income Taxes

Income tax expense is recognized based on the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end. For the three months ended June 30, 2024, federal and state income tax expense totaled $31,899 thousand compared to expense of $25,765 thousand for the three months ended June 30, 2023.

Six Months Ended June 30, 2024 Compared to the Six Months Ended June 30, 2023

Revenues, net of Discounts

Revenues, net of discounts for the six months ended June 30, 2024 was $555,953 thousand, an increase of 11% from $500,924 for the six months ended June 30, 2023. The increase in revenue was largely due to legalization of adult-use sales in Maryland, which began on July 1, 2023, continued growth in existing markets, as well as revenue generated from new retail stores opened in the current period, partially offset by price compression.

The Company generated revenue from 94 retail stores during the period compared to 83 in the same period of the prior year. Since June 30, 2023, the Company opened ten new Retail stores in Florida, one new Retail store in Nevada, and one new Retail store in New York. The Company also disposed of one Retail store in Massachusetts.

Cost of Goods Sold

Cost of goods sold are derived from retail purchases made by the Company from its third-party licensed producers operating within our state markets and costs related to the internal cultivation and production of cannabis. Cost of goods sold for the six months ended June 30, 2024 was $260,504 thousand, an increase of 4% from $250,923 thousand for the six months ended June 30, 2023, driven by increased volume from the launch of adult-use sales in Maryland as described above, and new retail store openings since June 30, 2023 in Florida, Nevada and New York.

Gross Profit

Gross profit for the six months ended June 30, 2024 was $295,449 thousand, representing a gross margin on the sale of branded cannabis flower and processed and packaged products including concentrates, edibles, topicals and other cannabis products, of 53%. This is compared to gross profit for the six months ended June 30, 2023 of $250,001 thousand or a 50% gross margin. The increase in gross profit (dollars) was directly attributable to the revenue increase as described above, while the increase in gross margin (percent) was primarily driven by an increase in Retail sales of Green Thumb-produced products.

Total Expenses

Total expenses for the six months ended June 30, 2024 were $170,758 thousand or 31% of revenues, net of discounts, resulting in an increase of $6,022 thousand over the same period in the prior year. Total expenses for the six months ended June 30, 2023 were $164,736 thousand or 33% of revenues, net of discounts. The increase in total expenses was attributable to increased costs associated with the launch of adult-use sales in Maryland, new Retail store openings as described above, and increased payroll costs, stemming from annual wage increases that took effect during the current quarter. The increase in total expenses was partially offset by favorable fair value adjustments associated with the Company's contingent consideration arrangements recorded during the six months ended June 30, 2024.

Total Other Income (Expense)

Total other income (expense) for the six months ended June 30, 2024 was $(8,377) thousand, an increase of $5,608 thousand over the same period in the prior year, primarily due to a decrease in capitalized interest during the six months ended June 30, 2024.

Income Before Provision for Income Taxes and Non-Controlling Interest

Income before provision for income taxes and non-controlling interest for the six months ended June 30, 2024 was $116,314 thousand, an increase of $33,818 thousand compared to the six months ended June 30, 2023.

As presented under the heading “Non-GAAP Measures” below, after adjusting for non-cash equity incentive compensation of $15,356 thousand and $13,620 thousand, and other nonoperating (income) expenses, of $(11,463) thousand and $5,430 thousand in the six months ended June 30, 2024 and 2023, respectively, Adjusted EBITDA was $184,344 thousand and $152,050 thousand, respectively.

Provision for Income Taxes

Income tax expense is recognized based on the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end. For the six months ended June 30, 2024, federal and state income tax expense totaled $64,048 thousand compared to expense of $59,401 thousand for the six months ended June 30, 2023.

Results of Operations by Segment

The following table summarizes revenues, net of discounts by segment for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				QTD Change
		2024		2023		$	%
		(in thousands)				Increase (Decrease)
Retail	$	204,656	$	188,044	$	16,612	9%
Consumer Packaged Goods		156,323		136,054		20,269	15%
Intersegment Eliminations		(80,832)		(71,710)		9,122	13%
Total Revenues, Net of Discounts	$	280,147	$	252,388	$	27,759	11%


		Six Months Ended June 30,				2024 vs. 2023
		2024		2023		$ Change	% Change
		(in thousands)				Increase (Decrease)
Retail	$	408,434	$	376,922	$	31,512	8%
Consumer Packaged Goods		306,235		261,671		44,564	17%
Intersegment Eliminations		(158,716)		(137,669)		21,047	15%
Total Revenues, Net of Discounts	$	555,953	$	500,924	$	55,029	11%

Three Months Ended June 30, 2024 Compared with the Three Months Ended June 30, 2023

Revenues, net of discounts, for the Retail segment were $204,656 thousand, an increase of $16,612 thousand or 9%, compared to the three months ended June 30, 2023. The increase in Retail revenues, net of discounts, was primarily driven by: (i) the legalization of adult-use sales in Maryland, which began on July 1, 2023, and (ii) revenue generated from new Retail store openings as described above, partially offset by price compression.

Revenues, net of discounts, for the Consumer Packaged Goods Segment were $156,323 thousand, an increase of $20,269 thousand or 15%, compared to the three months ended June 30, 2023. The increase in Consumer Packaged Goods revenues, net of discounts, was primarily driven by the legalization of adult-use sales in Maryland, which began on July 1, 2023, as well as increased production associated with the completion of various construction projects in 2023.

Intersegment eliminations associated with the Consumer Packaged Goods Segment were $(80,832) thousand, an increase of $9,122 thousand or 13% compared to the three months ended June 30, 2023. The increase in intersegment eliminations was driven by increased intercompany sales, primarily to Company-owned Retail stores in Maryland, New York and Pennsylvania. Consumer Packaged Goods revenues, net of intersegment eliminations, made up 27% of total revenues during the three months ended June 30, 2024 as compared to 25% during the three months ended June 30, 2023.

Due to the vertically integrated nature of the business, the Company reviews its revenue at the Retail and Consumer Packaged Goods level while reviewing its operating results on a consolidated basis.

Six Months Ended June 30, 2024 Compared with the Six Months Ended June 30, 2023

Revenues, net of discounts for the Retail segment were $408,434, an increase of $31,512 or 8%, compared to the six months ended June 30, 2023. The increase in Retail revenues, net of discounts, was primarily driven by: (i) the legalization of adult-use sales in Maryland, which began on July 1, 2023, and (ii) revenue generated from new Retail store openings as described above, partially offset by price compression.

Revenues, net of discounts, for the Consumer Packaged Goods Segment were $306,235 thousand, an increase of $44,564 thousand or 17%, compared to the six months ended June 30, 2023. The increase in Consumer Packaged Goods revenues was primarily driven by the legalization of adult-use sales in Maryland, which began on July 1, 2023, as well as increased production associated with the completion of various construction projects in 2023.

Intersegment eliminations associated with the Consumer Packaged Goods Segment were $158,716 thousand, an increase of $21,047 thousand or 15% compared to the six months ended June 30, 2023. The increase in intersegment eliminations was driven by increased intercompany sales to Company-owned retail stores primarily in Maryland, Pennsylvania, New York and New Jersey. Consumer Packaged Goods revenues, net of intersegment eliminations, made up 27% of total revenues during the six months ended June 30, 2024 as compared to 25% during the six months ended June 30, 2023.

Due to the vertically integrated nature of the business, the Company reviews its revenue at the Retail and Consumer Packaged Goods level while reviewing its operating results on a consolidated basis.

Drivers of Results of Operations

Revenue

The Company derives its revenue from two revenue streams: a Consumer Packaged Goods business in which it manufactures, sells and distributes its portfolio of Consumer Packaged Goods brands including &Shine, Beboe, Dogwalkers, Dr. Solomon’s, Good Green, incredibles, and RYTHM, primarily to third-party customers; and a Retail business in which it sells finished goods sourced primarily from third-party cannabis manufacturers in addition to the Company’s own Consumer Packaged Goods products direct to the end consumer in its Retail stores, as well as direct-to-consumer delivery where permitted by state law.

For the three and six months ended June 30, 2024, revenue was contributed from Retail and Consumer Packaged Goods sales across California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.

Gross Profit

Gross profit is revenue less cost of goods sold. Cost of goods sold includes the costs directly attributable to product sales and includes amounts paid for finished goods, such as flower, edibles, and concentrates, as well as packaging and other supplies, fees for services and processing, and allocated overhead which includes allocations of rent, utilities and related costs. Cannabis costs are affected by various state regulations that limit the sourcing and procurement of cannabis product, which may create fluctuations in gross profit over comparative periods as the regulatory environment changes. Gross margin measures our gross profit as a percentage of revenue.

During the three and six months ended June 30, 2024, the Company continued to be focused on creating sustainable, profitable growth of the Company’s business within its current markets while considering strategic acquisition and partnership opportunities.

Total Expenses

Total expenses other than the cost of goods sold consist of selling costs to support customer relationships and marketing and branding activities. It also includes a significant investment in the corporate infrastructure required to support the Company’s ongoing business.

Retail selling costs generally correlate to revenue. As new locations begin operations, these locations generally experience higher selling costs as a percentage of revenue compared to more established locations, which experience a more constant rate of selling costs. As a percentage of sales, the Company expects selling costs to remain constant in the more established locations and increase in the newer locations as business continues to grow.

General and administrative expenses also include costs incurred at the Company’s corporate offices, primarily related to back office personnel costs, including salaries, incentive compensation, benefits, stock-based compensation and other professional service costs, and fair value adjustments on the Company's contingent consideration arrangements. The Company expects to continue to invest considerably in this area to support the business by attracting and retaining top-tier talent. Furthermore, the Company anticipates an increase in stock-based compensation expenses related to recruiting and hiring talent, along with legal and professional fees associated with being a publicly traded company in Canada and registered with the SEC.

Provision for Income Taxes

The Company is subject to income taxes in the jurisdictions in which it operates and, consequently, income tax expense is a function of the allocation of taxable income by jurisdiction and the various activities that impact the timing of taxable events. As the Company operates in the federally illegal cannabis industry, it is subject to the limitations of the U.S. Internal Revenue Code of 1986, as amended (“IRC”) Section 280E, under which taxpayers are only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E and a higher effective tax rate than most industries. Therefore, the effective tax rate can be highly variable and may not necessarily correlate to pre-tax income or loss.

Non-GAAP Measures

EBITDA, and Adjusted EBITDA are non-GAAP measures and do not have standardized definitions under GAAP. The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented.


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Net Income Before Non-Controlling Interest	$	20,918	$	13,690	$	52,266	$	23,095
Interest Income, net		(2,314)		(1,531)		(4,417)		(3,262)
Interest Expense, net		5,981		2,869		13,495		6,685
Provision for Income Taxes		31,899		25,765		64,048		59,401
Total Other (Income) Expense		(2,464)		270		(701)		(654)
Depreciation and Amortization		27,985		24,234		55,760		47,735
Earnings before interest, taxes, depreciation and amortization (EBITDA) (non-GAAP measure)	$	82,005	$	65,297	$	180,451	$	133,000
Stock-based Compensation, Non-cash		8,866		7,381		15,356		13,620
Acquisition, Transaction and Other Non-operating Costs (Income)		2,925		3,138		(11,463)		5,430
Adjusted EBITDA (Non-GAAP Measure)	$	93,796	$	75,816	$	184,344	$	152,050

Liquidity, Financing Activities During the Period, and Capital Resources

As of June 30, 2024, and December 31, 2023 the Company had total current liabilities of $370,579 thousand and $126,050 thousand, respectively, and cash and cash equivalents of $196,142 thousand and $161,634 thousand, respectively, to meet its current obligations. The Company had working capital of $33,223 thousand as of June 30, 2024, a decrease of $183,489 thousand as compared to December 31, 2023. This decrease in working capital was primarily associated with the change in classification of the April 30, 2021 private placement debt from a long-term liability to a current liability.

The Company generates cash from its operations and deploys its capital reserves to acquire and develop assets capable of producing additional revenues and earnings over both the immediate and long term. Capital reserves are primarily being utilized for capital expenditures, facility improvements, strategic investment opportunities, product development and marketing, as well as customer, supplier, and investor and industry relations.

The Company takes a cautious approach in allocating its capital to maximize its returns while ensuring appropriate liquidity. Given the current uncertainty of the future economic environment, the Company has taken additional measures in monitoring and deploying its capital to minimize the negative impact on its current operations and expansion plans.

Cash Flows

Cash Provided by (Used in) Operating, Investing and Financing Activities

Net cash provided by (used in) operating, investing and financing activities for the six months ended June 30, 2024 and 2023 were as follows:


		Six Months Ended June 30,
		2024		2023
		(in thousands)
Net Cash Provided by Operating Activities	$	104,174	$	93,028
Net Cash Used in Investing Activities	$	(34,323)	$	(131,542)
Net Cash (Used in) Provided by Financing Activities	$	(35,343)	$	9,858

Off-Balance Sheet Arrangements

As of June 30, 2024, the Company does not have any off-balance-sheet arrangements that have, or are reasonably likely to have, a current or future effect on the results of operations or financial condition of the Company, including, and without limitation, such considerations as liquidity and capital resources.

Changes in or Adoption of Accounting Practices

Refer to the discussion of recently adopted/issued accounting pronouncements under Part I, Item 1, Notes to Unaudited Interim Condensed Consolidated Financial Statements, Note 1—Overview and Basis of Presentation.

Critical Accounting Policies and Significant Judgments and Estimates

There were no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our 2023 Form 10-K.

ITEM 3. QUANTITAVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our market risk disclosures as set forth in Part II Item 7A of our 2023 Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company's management carried out an evaluation under the supervision and with the participation of the Company's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Based upon that evaluation, management concluded that our disclosure controls and procedures were effective as of June 30, 2024.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company's internal control over financial reporting during the second quarter of 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Control Systems

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, will be or have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is a party to a variety of legal proceedings that arise out of operations in the normal course of business. While the results of these legal proceedings cannot be predicted with certainty, the Company believes that the final outcome of these proceedings will not have a material adverse effect, individually or in the aggregate, on our results of operations or financial condition.

ITEM 1A. RISK FACTORS

For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our 2023 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

Subordinate Voting Shares

None.

Multiple Voting Shares

None.

Super Voting Shares

None.

Recent Issuer Purchases of Equity Securities

The following table sets forth repurchases of our Subordinate Voting Shares during the six months ended June 30, 2024:


(Dollars in thousands except per share amounts)
Period	Total Number of Shares Purchased		Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Program (1)		Approximate Dollar Value of Shares that may yet be Purchased Under the Program
January 1, 2024 through January 31, 2024	—	$	—	—	$	—
February 1, 2024 through February 29, 2024	—		—	—		—
March 1, 2024 through March 31, 2024	1,067,000		12.27	1,067,000		46,600
April 1, 2024 through April 30, 2024	—		—	—		—
May 1, 2024 through May 31, 2024	659,100		12.05	659,100		38,660
June 1, 2024 through June 30, 2024	998,900		12.33	998,900		26,700
	2,725,000	$	12.27	2,725,000	$	26,700

(1) On September 5, 2023, the Company's Board of Directors authorized the repurchase of up to 5%, or 10,486,951 of its Subordinate Voting Shares over a 12-month period at an aggregate cost of up to $50,000 thousand. On February 28, 2024, the Company's Board of Directors authorized an increase in its share repurchase program of $50,000 thousand. During the six months ended June 30, 2024, the Company repurchased 2,725,000 Subordinate Voting Shares at an average price of $12.27 per share, bringing the total remaining repurchase ability to approximately $26,700 thousand through September 10, 2024.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

(c) Rule 10b5-1 Trading Plans. During the three months ended June 30, 2024, none of the Company's directors or Section 16 officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement”, as each term is defined in the Item 408(a) of Regulation S-K.

ITEM 6. EXHIBITS

The following exhibits are filed with this report:


31.1	CERTIFICATE OF CHIEF EXECUTIVE OFFICER

31.2	CERTIFICATE OF CHIEF FINANCIAL OFFICER

32.1	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

32.2	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

101.INS	Inline XBRL Instance Document

101.SCH	Inline XBRL Taxonomy Extension Schema Document

101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document

104	Cover Page Interactive Data File (embedded with Inline XBRL File)

SIGNATURES

Pursuant to requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    GREEN THUMB INDUSTRIES INC.

   

    /s/Benjamin Kovler

    By: Benjamin Kovler

   

    Title: Chief Executive Officer

   

Date: August 6, 2024

    GREEN THUMB INDUSTRIES INC.

   

    /s/Mathew Faulkner

    By: Mathew Faulkner

   

    Title: Chief Financial Officer

   

Date: August 6, 2024

Exhibit 31.1

CERTIFICATE OF CHIEF EXECUTIVE OFFICER

I, Benjamin Kovler, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Green Thumb Industries Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

    /s/Benjamin Kovler

    By: Benjamin Kovler

   

    Title: Chief Executive Officer

   

Date: August 6, 2024

Exhibit 31.2

CERTIFICATE OF CHIEF FINANCIAL OFFICER

I, Mathew Faulkner, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Green Thumb Industries Inc.;

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

    /s/Mathew Faulkner

    By: Mathew Faulkner

   

    Title: Chief Financial Officer

   

Date: August 6, 2024

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Green Thumb Industries Inc. (the “Company”) on Form 10-Q for the three and six months ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Benjamin Kovler, Chief Executive Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

    /s/Benjamin Kovler

    By: Benjamin Kovler

   

    Title: Chief Executive Officer

   

Date: August 6, 2024

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Green Thumb Industries Inc. (the “Company”) on Form 10-Q for the three and six months ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mathew Faulkner, Chief Financial Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

    /s/Mathew Faulkner

    By: Mathew Faulkner

   

    Title: Chief Financial Officer

   

Date: August 6, 2024

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2024	Aug. 01, 2024
Document Information [Line Items]
Document Type	10-Q
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity File Number	000-56132
Entity Registrant Name	GREEN THUMB INDUSTRIES INC.
Entity Central Index Key	0001795139
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, Address Line One	325 West Huron Street
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60654
Entity Tax Identification Number	98-1437430
City Area Code	312
Local Phone Number	471-6720
Entity Incorporation, State or Country Code	A1
Document Quarterly Report	true
Document Transition Report	false
Subordinate Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Subordinate Voting Shares
Entity Common Stock, Shares Outstanding		211,380,808
Super Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Super Voting Shares
Entity Common Stock, Shares Outstanding		206,690
Multiple Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Multiple Voting Shares
Entity Common Stock, Shares Outstanding		37,683

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and Cash Equivalents	$ 196,142	$ 161,634
Accounts Receivable, Net	49,335	42,975
Income Tax Receivable	3,486	0
Inventories, Net	130,530	112,970
Prepaid Expenses	19,497	19,801
Other Current Assets	4,812	5,382
Total Current Assets	403,802	342,762
Property and Equipment, Net	694,039	687,106
Right of Use Assets, Net	247,533	238,369
Investments	61,412	64,361
Investment in Associates	23,484	24,942
Note Receivable	3,550	550
Intangible Assets, Net	513,434	538,678
Goodwill	589,691	589,691
Deferred Tax Assets	1,041	1,041
Deposits and Other Assets	2,568	2,557
TOTAL ASSETS	2,540,554	2,490,057
Current Liabilities:
Accounts Payable	29,433	24,495
Accrued Liabilities	62,776	59,552
Compensation Payable	12,917	16,005
Current Portion of Notes Payable	227,265	2,996
Current Portion of Lease Liabilities	12,853	12,297
Income Tax Payable	25,335	10,705
Total Current Liabilities	370,579	126,050
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion	261,031	249,464
Notes Payable, Net of Current Portion and Debt Discount	82,478	305,527
Contingent Consideration Payable	0	33,250
Deferred Income Taxes	72,510	72,510
TOTAL LIABILITIES	786,598	786,801
COMMITMENTS AND CONTINGENCIES
SHARE HOLDERS' EQUITY
Share Capital	1,742,784	1,703,852
Contributed (Deficit) Surplus	(31,865)	7,871
Deferred Share Issuances	12,973	12,973
Accumulated Earnings (Deficit)	29,970	(21,818)
Equity of Green Thumb Industries Inc.	1,753,862	1,702,878
Noncontrolling interests	94	378
TOTAL SHAREHOLDERS' EQUITY	1,753,956	1,703,256
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 2,540,554	$ 2,490,057

Condensed Consolidated Balance Sheets (Parenthetical) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Subordinate Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	211,129,419	209,871,792
Common Stock, Shares, Outstanding	211,129,419	209,871,792
Multiple Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	37,683	38,531
Common Stock, Shares, Outstanding	37,683	38,531
Super Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	206,690	216,690
Common Stock, Shares, Outstanding	206,690	216,690

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues, net of discounts	$ 280,147	$ 252,388	$ 555,953	$ 500,924
Cost of Goods Sold	(129,627)	(127,108)	(260,504)	(250,923)
Gross Profit	150,520	125,280	295,449	250,001
Expenses:
Selling, General, and Administrative	96,500	84,217	170,758	164,736
Total Expenses	96,500	84,217	170,758	164,736
Income From Operations	54,020	41,063	124,691	85,265
Other Income (Expense):
Other Income (Expense), Net	2,464	(270)	701	654
Interest Income, net	2,314	1,531	4,417	3,262
Interest Expense, net	(5,981)	(2,869)	(13,495)	(6,685)
Total Other Expense	(1,203)	(1,608)	(8,377)	(2,769)
Income Before Provision for Income Taxes And Non-Controlling Interest	52,817	39,455	116,314	82,496
Provision For Income Taxes	31,899	25,765	64,048	59,401
Net Income Before Non-Controlling Interest	20,918	13,690	52,266	23,095
Net Income Attributable to Non-Controlling Interest	206	290	478	556
Net Income Attributable To Green Thumb Industries Inc.	$ 20,712	$ 13,400	$ 51,788	$ 22,539
Net Income per share - basic	$ 0.09	$ 0.05	$ 0.22	$ 0.09
Net Income per share - diluted	$ 0.09	$ 0.05	$ 0.22	$ 0.09
Weighted average number of shares outstanding - basic	237,416,373	238,000,135	237,083,912	237,700,856
Weighted average number of shares outstanding - diluted	240,137,922	238,423,288	240,768,497	239,455,964

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Share Capital [Member]	Contributed Surplus (Deficit) [Member]	Deferred Share Issuance [Member]	Accumulated Earnings (Deficit) [Member]	Non-Controlling Interest [Member]
Beginning balance at Dec. 31, 2022	$ 1,665,432	$ 1,663,557	$ 23,233	$ 36,211	$ (58,085)	$ 516
Issuance of deferred shares		20,454		(20,454)
Distribution of Contingent Consideration	6,070	6,070
Indemnification of deferred shares associated with post acquisition costs	(2,784)			(2,784)
Exercise of options and RSUs	916	3,348	(2,432)
Stock-based compensation	13,620		13,620
Distributions to limited liability company unit holders	(533)					(533)
Repurchase of Subordinate Voting Shares	0
Net income	23,095				22,539	556
Ending balance at Jun. 30, 2023	1,705,816	1,693,429	34,421	12,973	(35,546)	539
Beginning balance at Mar. 31, 2023	1,681,146	1,683,671	28,959	17,105	(48,946)	357
Issuance of deferred shares		1,348		(1,348)
Distribution of Contingent Consideration	6,070	6,070
Indemnification of deferred shares associated with post acquisition costs	(2,784)			(2,784)
Exercise of options and RSUs	421	2,340	(1,919)
Stock-based compensation	7,381		7,381
Distributions to limited liability company unit holders	(108)					(108)
Net income	13,690				13,400	290
Ending balance at Jun. 30, 2023	1,705,816	1,693,429	34,421	12,973	(35,546)	539
Beginning balance at Dec. 31, 2023	1,703,256	1,703,852	7,871	12,973	(21,818)	378
Distribution of Contingent Consideration	17,259	17,259
Exercise of options and RSUs	5,938	10,789	(4,851)
Stock-based compensation	15,356		15,356
Options exercised through net share settlement	(5,909)	10,884	(16,793)
Distributions to limited liability company unit holders	(762)					(762)
Repurchase of Subordinate Voting Shares	(33,448)		(33,448)
Net income	52,266				51,788	478
Ending balance at Jun. 30, 2024	1,753,956	1,742,784	(31,865)	12,973	29,970	94
Beginning balance at Mar. 31, 2024	1,747,130	1,727,584	(2,816)	12,973	9,258	131
Exercise of options and RSUs	2,630	5,157	(2,527)
Stock-based compensation	8,866		8,866
Options exercised through net share settlement	(5,455)	10,043	(15,498)
Distributions to limited liability company unit holders	(243)					(243)
Repurchase of Subordinate Voting Shares	(19,890)		(19,890)
Net income	20,918				20,712	206
Ending balance at Jun. 30, 2024	$ 1,753,956	$ 1,742,784	$ (31,865)	$ 12,973	$ 29,970	$ 94

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
CASH FLOW FROM OPERATING ACTIVITIES
Net Income (Loss)	$ 51,788	$ 22,539
Net income attributable to non-controlling interest	478	556
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	55,760	47,735
Amortization of operating lease assets	24,676	24,368
Loss on disposal of property and equipment	875	1,951
Impairment of long-lived property and equipment		285
Loss on equity method investments	1,100	750
Loss from lease modification	219	0
Stock based compensation	15,356	13,620
(Increase) decrease in fair value of investments	(334)	928
Gain on settlement of contingent consideration	(15,991)	0
Increase in fair value of contingent consideration	0	2,150
Decrease in fair value of warrants	(1,534)	(2,263)
Gain on indemnification of deferred shares associated with post acquisition costs.	0	(2,784)
Amortization of debt discount	2,853	4,762
Changes in operating assets and liabilities:
Accounts receivable, net	(6,359)	(8,265)
Inventories, net	(17,561)	(9,097)
Prepaid expenses and other current assets	874	(3,285)
Deposits and other assets	(10)	676
Accounts payable	4,938	9,071
Accrued liabilities	(2,164)	3,365
Operating lease liabilities	(21,934)	(21,589)
Income tax receivable and payable, net	11,144	7,555
NET CASH PROVIDED BY OPERATING ACTIVITIES	104,174	93,028
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment	(34,963)	(129,392)
Proceeds from disposal of property and equipment	0	319
Investments in securities and associates	(5,608)	(2,800)
Proceeds from equity investments and notes receivable	6,248	331
NET CASH USED IN INVESTING ACTIVITIES	(34,323)	(131,542)
CASH FLOW FROM FINANCING ACTIVITIES
Distributions to limited liability company unit holders	(762)	(533)
Repurchase of Subordinate Voting Shares	(33,448)	0
Payments for taxes related to net share settlement of equity awards	(5,438)	0
Proceeds from exercise of options and warrants	5,938	916
Proceeds from issuance of notes payable	0	10,134
Principal repayment of notes payable	(1,633)	(659)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(35,343)	9,858
CASH, CASH EQUIVALENTS :
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	34,508	(28,656)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH BEGINNING OF PERIOD	161,634	177,682
CASH, CASH EQUIVALENTS AND RESTRICTED CASH END OF PERIOD	196,142	149,026
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	10,975	10,086
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	3,358	12,630
Noncash increase in right of use asset	(10,333)	(3,928)
Noncash increase in lease liability	10,333	3,928
Issuance of shares associated with contingent consideration	17,259	6,070
Deferred share distributions	$ 0	$ (20,454)

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 20,712	$ 13,400	$ 51,788	$ 22,539

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Overview and Basis of Presentation

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Overview and Basis of Presentation

1. Overview and Basis of Presentation

(a) Description of Business

(b) Basis of Presentation

There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2023 Form 10-K.

(d) Earnings per Share

1. Overview and Basis of Presentation (Continued)

(d) Earnings per Share (Continued)

(e) Recently Issued Accounting Standards

(i)

(ii)

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

Inventories

6 Months Ended

Jun. 30, 2024

Inventory Disclosure [Abstract]

Inventories

2. INVENTORIES

The Company’s inventories include the following at June 30, 2024 and December 31, 2023:


		June 30, 2024		December 31, 2023
		(in thousands)
Raw Material	$	2,205	$	1,547
Packaging and Miscellaneous		11,021		10,661
Work in Process		51,219		47,029
Finished Goods		70,320		57,631
Reserve for Obsolete Inventory		(4,235)		(3,898)
Total Inventories, Net	$	130,530	$	112,970

Property and Equipment

6 Months Ended

Jun. 30, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment

3. PROPERTY AND EQUIPMENT

At June 30, 2024 and December 31, 2023, property and equipment consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Buildings and Improvements	$	354,195	$	353,912
Equipment, Computers and Furniture		182,041		171,522
Leasehold Improvements		222,073		200,232
Land Improvements		1,168		1,046
Capitalized Interest		31,603		30,817
Total Property and Equipment		791,080		757,529
Less: Accumulated Depreciation		(157,168)		(127,290)
Property and Equipment, net		633,912		630,239
Land		33,725		33,725
Assets Under Construction		26,402		23,142
Property and Equipment, net	$	694,039	$	687,106

Intangible Assets And Goodwill

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

4. INTANGIBLE ASSETS AND GOODWILL

(a) Intangible Assets

At June 30, 2024 and December 31, 2023, intangible assets consisted of the following:


		June 30, 2024						December 31, 2023
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	179,813	$	480,903	$	660,716	$	157,764	$	502,952
Trademarks		41,511		14,746		26,765		41,511		13,378		28,133
Customer Relationships		24,438		18,672		5,766		24,438		16,927		7,511
Non-Competition Agreements		2,565		2,565		—		2,565		2,483		82
Total Intangible Assets	$	729,230	$	215,796	$	513,434	$	729,230	$	190,552	$	538,678

The following table outlines the estimated annual amortization expense related to intangible assets as of June 30, 2024:


		Estimated Amortization
Year Ending December 31,		(in thousands)
Remainder of 2024	$	25,148
2025		50,294
2026		47,332
2027		46,803
2028		46,803
2029 and Thereafter		297,054
	$	513,434

As of June 30, 2024, the weighted average amortization period remaining for intangible assets was 10.91 years.

(b) Goodwill

At June 30, 2024 and December 31, 2023 the balances of goodwill, by segment, consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Retail	$	273,802	$	273,802
Consumer Packaged Goods		315,889		315,889
Total	$	589,691	$	589,691

Investments

6 Months Ended

Jun. 30, 2024

Investments [Abstract]

Investments

5. INVESTMENTS

The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2024 and year ended December 31, 2023:


		June 30, 2024		December 31, 2023
		(in thousands)
Beginning	$	64,361	$	74,169
Additions		2,965		8,200
Disposals		(6,248)		(498)
Fair value adjustment		334		(17,460)
Transfers and other		—		(50)
Ending	$	61,412	$	64,361


	Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
	(in thousands)
Equity Investments	$	(481)	$	(655)	$	158	$	(1,134)
Notes Receivable Instruments		9		—		9		—
Accrued Interest on Notes Receivable Instruments		84		78		167		206
Net fair value gains (losses)	$	(388)	$	(577)	$	334	$	(928)

(a) Equity Investments

These investments are classified as trading securities and are included within investments on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

5. INVESTMENTS (Continued)

(a) Equity Investments (Continued)

(b) Notes Receivable Instruments

These notes receivable instruments are classified as trading securities and are included within investments on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

Leases

6 Months Ended

Jun. 30, 2024

Leases [Abstract]

Leases

6. LEASES

(a) Operating Leases

Other information related to operating leases as of June 30, 2024 and December 31, 2023 were as follows:


	June 30, 2024	December 31, 2023
Weighted average remaining lease term (years)	11.19	11.75
Weighted average discount rate	12.29%	12.40%

Maturities of lease liabilities for operating leases as of June 30, 2024 were as follows:


		Maturities of Lease Liability
Year Ending December 31,		Third-Party		Related Party		Total
		(in thousands)
Remainder of 2024	$	22,626	$	292	$	22,918
2025		44,893		592		45,485
2026		45,102		603		45,705
2027		45,622		572		46,194
2028		44,898		364		45,262
2029 and Thereafter		329,894		1,364		331,258
Total Lease Payments		533,035		3,787		536,822
Less: Interest		(261,707)		(1,231)		(262,938)
Present Value of Lease Liability	$	271,328	$	2,556	$	273,884

(b) Related Party Operating Leases

Notes Payable

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Notes Payable

7. NOTES PAYABLE

At June 30, 2024 and December 31, 2023, notes payable consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Charitable contributions1	$	48	$	351
Private placement debt dated April 30, 20212		224,435		221,680
Mortgage notes3		85,260		86,492
Total notes payable		309,743		308,523
Less: current portion of notes payable		(227,265)		(2,996)
Notes payable, net of current portion	$	82,478	$	305,527

(a) April 30, 2021 Private Placement Financing:

Warrants

6 Months Ended

Jun. 30, 2024

Warrants and Rights Note Disclosure [Abstract]

Warrants

8. WARRANTS

The following table summarizes the number of warrants outstanding as of June 30, 2024 and December 31, 2023:


	Liability Classified				Equity Classified
	Number of Shares		Weighted Average Exercise Price (C$)	Weighted Average Remaining Contractual Life	Number of Shares		Weighted Average Exercise Price (USD)	Weighted Average Remaining Contractual Life
Balance as of December 31, 2023	1,997,208	C$	18.03	0.50	1,737,347	$	31.83	2.38
Warrants Expired	(1,606,533)		—	—	—		—	—
Balance as of June 30, 2024	390,675	C$	12.42	0.46	1,737,347	$	31.83	1.88

(a) Liability Classified Warrants Outstanding

The following table summarizes the fair value of the liability classified warrants at June 30, 2024 and December 31, 2023:


				Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		June 30, 2024		December 31, 2023		Change
				(in thousands)
Private Placement Financing Warrants Issued May 2019	C$19.39	—	$	—	$	1,673	$	(1,673)
Modification Warrants Issued November 2019	C$12.04	316,947		1,280		1,151		129
Additional Modification Warrants Issued May 2020	C$14.03	73,728		303		293		10
Totals		390,675	$	1,583	$	3,117	$	(1,534)


	June 30,	December 31,
Significant Assumptions	2024	2023
Volatility	74.81%-79.97%	61.76% - 74.31%
Remaining Term	0.36-0.89 years	0.39-1.39 years
Risk Free Rate	4.02%	3.91%

8. WARRANTS (Continued)

(b) Equity Classified Warrants Outstanding


				Issuance Date Fair Value
		Warrants		June 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price	Outstanding		2024		2023
				(in thousands)
Mortgage Warrants Issued June 2020	$9.10	35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$32.68	1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$30.02	243,303		2,616		2,616
Totals		1,737,347	$	25,056	$	25,056


Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%

Share Capital

6 Months Ended

Jun. 30, 2024

Stockholders' Equity Note [Abstract]

Share Capital

9. SHARE CAPITAL

(a) Authorized

The Company has the following classes of share capital, with each class having no par value:

(i) Subordinate Voting Shares

(ii) Multiple Voting Shares

(iii) Super Voting Shares

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:


	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2024	209,871,792	38,531	216,690
Distribution of contingent consideration	1,250,000	—	—
Issuance of shares upon exercise of options	843,387	—	—
Issuances of shares upon vesting of RSUs	804,440	—	—
Repurchase of Subordinate Voting Shares	(2,725,000)	—	—
Exchange of shares	1,084,800	(848)	(10,000)
As at June 30, 2024	211,129,419	37,683	206,690

9. SHARE CAPITAL (Continued)

(i) Distribution of Contingent Consideration

Dharma Pharmaceuticals, LLC

(ii) Repurchase of Subordinate Voting Shares

9. SHARE CAPITAL (Continued)

Stock option activity is summarized as follows:


	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life
Balance as of December 31, 2023	10,071,467	$11.75	4.31
Granted	797,289	14.96
Exercised	(843,387)	8.81
Forfeited	(828,488)	14.06
Balance as of June 30, 2024	9,196,881	$12.44	4.41
Exercisable as of June 30, 2024	4,214,462	$8.00	3.78


	June 30,	December 31,
	2024	2023
Risk-free interest rate	3.25% - 3.92%	3.06% - 4.32%
Expected dividend yield	0%	0%
Expected volatility	62% - 64%	64%
Expected option life	4.46 - 4.5 years	3.5 – 4.5 years

As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.

The following table summarizes the number of unvested RSU awards as of June 30, 2024 and December 31, 2023 and the changes during the six months ended June 30, 2024:


	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2023	3,620,638	$	9.25
Granted	2,458,964		14.75
Forfeited	(609,639)		11.29
Vested	(804,440)		9.89
Unvested Shares at June 30, 2024	4,665,523	$	11.88

The stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was as follows:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Stock options expense	$	2,637	$	4,303	$	5,694	$	8,786
Restricted Stock Units		6,229		3,078		9,662		4,834
Total Stock Based Compensation Expense	$	8,866	$	7,381	$	15,356	$	13,620

As of June 30, 2024, $63,591 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.21 years.

Income Tax Expense

6 Months Ended

Jun. 30, 2024

Income Tax Disclosure [Abstract]

Income Tax Expense

10. INCOME TAX EXPENSE

The following table summarizes the Company’s income tax expense and effective tax rates for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
Income before Income Taxes	$	52,817	$	39,455	$	116,314	$	82,496
Income Tax Expense		31,899		25,765		64,048		59,401
Effective Tax Rate		60.4%		65.3%		55.1%		72.0%

Taxes paid during the six months ended June 30, 2024 and 2023 were $52,904 thousand and $52,134 thousand, respectively.

Other Income (Expense)

6 Months Ended

Jun. 30, 2024

Other Income and Expenses [Abstract]

Other Income (Expense)

11. OTHER INCOME (EXPENSE)

For the three and six months ended June 30, 2024 and 2023 other income (expense) was comprised of the following:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	(472)	$	(655)	$	167	$	(1,134)
Fair value adjustments on warrants issued		3,641		621		1,534		2,263
Loss from equity method investments		(772)		(432)		(1,100)		(750)
Other		67		196		100		275
Total Other Income (Expense)	$	2,464	$	(270)	$	701	$	654

Commitments and Contingencies

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12. COMMITMENTS AND CONTINGENCIES

(a) Contingencies

(b) Claims and Litigation

As of June 30, 2024, the Company held approximately $5,400 thousand of open construction commitments to contractors on work being performed.

Fair Value Measurements

6 Months Ended

Jun. 30, 2024

Disclosure Text Block Supplement [Abstract]

Fair Value Measurements

13. FAIR VALUE MEASUREMENTS

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3 – Inputs for the asset or liability that are not based on observable market data.

(a) Financial Instruments


		As of June 30, 2024
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	196,142	$	—	$	—	$	196,142
Investments		24,695		—		36,717		61,412
Warrant Liability		—		—		(1,583)		(1,583)
	$	220,837	$	—	$	35,134	$	255,971


		As of December 31, 2023
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	161,634	$	—	$	—	$	161,634
Investments		24,215		—		40,146		64,361
Contingent Consideration Payable		—		—		(33,250)		(33,250)
Warrant Liability		—		—		(3,117)		(3,117)
	$	185,849	$	—	$	3,779	$	189,628

Segment Reporting

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Segment Reporting

14. SEGMENT REPORTING

The below table presents revenues by type for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	204,656	$	188,044	$	408,434	$	376,922
Consumer Packaged Goods		156,323		136,054		306,235		261,671
Intersegment Eliminations		(80,832)		(71,710)		(158,716)		(137,669)
Total Revenues, Net of Discounts	$	280,147	$	252,388	$	555,953	$	500,924
Depreciation and Amortization
Retail	$	10,436	$	9,109	$	20,683	$	17,941
Consumer Packaged Goods		17,549		15,125		35,077		29,794
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	27,985	$	24,234	$	55,760	$	47,735
Income Taxes
Retail	$	16,405	$	13,328	$	33,969	$	32,339
Consumer Packaged Goods		15,494		12,437		30,079		27,062
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	31,899	$	25,765	$	64,048	$	59,401

Significant Accounting Policies (Policies)	6 Months Ended
Significant Accounting Policies (Policies)	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP, have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.
Significant Accounting Policies	Significant Accounting Policies There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2023 Form 10-K.
Earnings per Share	Earnings per Share Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of June 30, 2024, the Company had 9,196,881 options, 4,665,523 restricted stock units and 2,128,022 warrants outstanding. As of June 30, 2023, the Company had 10,874,051 options, 3,453,460 restricted stock units and 3,734,555 warrants outstanding. Earnings per Share (Continued) In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended June 30, 2024, the computation of diluted earnings per share included 1,632,323 options, 971,792 restricted stock units, and 117,434 warrants. For the six months ended June 30, 2024, the computation of diluted earnings per share included 1,625,478 options, 1,939,848 restricted stock units, and 119,259 warrants. For the three months ended June 30, 2023, the computation of diluted earnings per share included 135,894 options and 287,259 restricted stock units. For the six months ended June 30, 2023, the computation of diluted earnings per share included 167,191 options and 1,587,917 restricted stock units. There were no dilutive warrants during the three and six months ended June 30, 2023 as the strike price was greater than the average stock price for the period. For the three and six months ended June 30, 2024, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 896,810 and 978,895, respectively. For the three and six months ended June 30, 2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 3,399,518 and 3,473,866, respectively.
Recently Issued Accounting Standards	Recently Issued Accounting Standards (i) In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, to provide enhanced segment disclosures. The standard will require disclosures about significant segment expense categories and amounts for each reportable segment, for all periods presented. Additionally, the standard requires public entities to disclose the title and position of the Chief Operating Decision Maker (“CODM”) in the consolidated financial statements. These enhanced disclosures are required for all entities on an interim and annual basis, effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. (ii) In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to provide enhancements to annual income tax disclosures. The standard will require more detailed information in the rate reconciliation table and for income taxes paid, among other enhancements. The standard is effective for years beginning after December 15, 2024 and early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

Inventories (Tables)

6 Months Ended

Jun. 30, 2024

Inventory Disclosure [Abstract]

Summary of inventory

The Company’s inventories include the following at June 30, 2024 and December 31, 2023:


		June 30, 2024		December 31, 2023
		(in thousands)
Raw Material	$	2,205	$	1,547
Packaging and Miscellaneous		11,021		10,661
Work in Process		51,219		47,029
Finished Goods		70,320		57,631
Reserve for Obsolete Inventory		(4,235)		(3,898)
Total Inventories, Net	$	130,530	$	112,970

Property and Equipment (Tables)

6 Months Ended

Jun. 30, 2024

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

At June 30, 2024 and December 31, 2023, property and equipment consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Buildings and Improvements	$	354,195	$	353,912
Equipment, Computers and Furniture		182,041		171,522
Leasehold Improvements		222,073		200,232
Land Improvements		1,168		1,046
Capitalized Interest		31,603		30,817
Total Property and Equipment		791,080		757,529
Less: Accumulated Depreciation		(157,168)		(127,290)
Property and Equipment, net		633,912		630,239
Land		33,725		33,725
Assets Under Construction		26,402		23,142
Property and Equipment, net	$	694,039	$	687,106

Intangible Assets And Goodwill (Tables)

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of intangible assets

At June 30, 2024 and December 31, 2023, intangible assets consisted of the following:


		June 30, 2024						December 31, 2023
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	179,813	$	480,903	$	660,716	$	157,764	$	502,952
Trademarks		41,511		14,746		26,765		41,511		13,378		28,133
Customer Relationships		24,438		18,672		5,766		24,438		16,927		7,511
Non-Competition Agreements		2,565		2,565		—		2,565		2,483		82
Total Intangible Assets	$	729,230	$	215,796	$	513,434	$	729,230	$	190,552	$	538,678

Summary of estimated annual amortization expense related to intangible assets

The following table outlines the estimated annual amortization expense related to intangible assets as of June 30, 2024:


		Estimated Amortization
Year Ending December 31,		(in thousands)
Remainder of 2024	$	25,148
2025		50,294
2026		47,332
2027		46,803
2028		46,803
2029 and Thereafter		297,054
	$	513,434

Summary of Goodwill And Intangible Assets Disclosure

At June 30, 2024 and December 31, 2023 the balances of goodwill, by segment, consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Retail	$	273,802	$	273,802
Consumer Packaged Goods		315,889		315,889
Total	$	589,691	$	589,691

Investments (Tables)

6 Months Ended

Jun. 30, 2024

Investments [Abstract]

Schedule Of Long Term Investments

The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2024 and year ended December 31, 2023:


		June 30, 2024		December 31, 2023
		(in thousands)
Beginning	$	64,361	$	74,169
Additions		2,965		8,200
Disposals		(6,248)		(498)
Fair value adjustment		334		(17,460)
Transfers and other		—		(50)
Ending	$	61,412	$	64,361

Schedule of Change in Fair Value of Company's Investments


	Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
	(in thousands)
Equity Investments	$	(481)	$	(655)	$	158	$	(1,134)
Notes Receivable Instruments		9		—		9		—
Accrued Interest on Notes Receivable Instruments		84		78		167		206
Net fair value gains (losses)	$	(388)	$	(577)	$	334	$	(928)

Leases (Tables)

6 Months Ended

Jun. 30, 2024

Leases [Abstract]

Schedule Of Other Information Related To Operating Leases

Other information related to operating leases as of June 30, 2024 and December 31, 2023 were as follows:


	June 30, 2024	December 31, 2023
Weighted average remaining lease term (years)	11.19	11.75
Weighted average discount rate	12.29%	12.40%

Lessee, Operating Lease, Liability, Maturity

Maturities of lease liabilities for operating leases as of June 30, 2024 were as follows:


		Maturities of Lease Liability
Year Ending December 31,		Third-Party		Related Party		Total
		(in thousands)
Remainder of 2024	$	22,626	$	292	$	22,918
2025		44,893		592		45,485
2026		45,102		603		45,705
2027		45,622		572		46,194
2028		44,898		364		45,262
2029 and Thereafter		329,894		1,364		331,258
Total Lease Payments		533,035		3,787		536,822
Less: Interest		(261,707)		(1,231)		(262,938)
Present Value of Lease Liability	$	271,328	$	2,556	$	273,884

Notes Payable (Tables)

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Schedule of Debt

At June 30, 2024 and December 31, 2023, notes payable consisted of the following:


		June 30, 2024		December 31, 2023
		(in thousands)
Charitable contributions1	$	48	$	351
Private placement debt dated April 30, 20212		224,435		221,680
Mortgage notes3		85,260		86,492
Total notes payable		309,743		308,523
Less: current portion of notes payable		(227,265)		(2,996)
Notes payable, net of current portion	$	82,478	$	305,527

Warrants (Tables)

3 Months Ended

6 Months Ended

Mar. 31, 2024

Jun. 30, 2024

Class of Warrant or Right [Line Items]

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the number of warrants outstanding as of June 30, 2024 and December 31, 2023:


	Liability Classified				Equity Classified
	Number of Shares		Weighted Average Exercise Price (C$)	Weighted Average Remaining Contractual Life	Number of Shares		Weighted Average Exercise Price (USD)	Weighted Average Remaining Contractual Life
Balance as of December 31, 2023	1,997,208	C$	18.03	0.50	1,737,347	$	31.83	2.38
Warrants Expired	(1,606,533)		—	—	—		—	—
Balance as of June 30, 2024	390,675	C$	12.42	0.46	1,737,347	$	31.83	1.88

Liability Classified Warrant [member]

Class of Warrant or Right [Line Items]

Schedule Of Fair Value Of Warrant Liability

The following table summarizes the fair value of the liability classified warrants at June 30, 2024 and December 31, 2023:


				Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		June 30, 2024		December 31, 2023		Change
				(in thousands)
Private Placement Financing Warrants Issued May 2019	C$19.39	—	$	—	$	1,673	$	(1,673)
Modification Warrants Issued November 2019	C$12.04	316,947		1,280		1,151		129
Additional Modification Warrants Issued May 2020	C$14.03	73,728		303		293		10
Totals		390,675	$	1,583	$	3,117	$	(1,534)

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability


	June 30,	December 31,
Significant Assumptions	2024	2023
Volatility	74.81%-79.97%	61.76% - 74.31%
Remaining Term	0.36-0.89 years	0.39-1.39 years
Risk Free Rate	4.02%	3.91%

Equity Classified Warrant [member]

Class of Warrant or Right [Line Items]

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the carrying amounts of the Company's equity classified warrants at June 30, 2024 and December 31, 2023:


				Issuance Date Fair Value
		Warrants		June 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price	Outstanding		2024		2023
				(in thousands)
Mortgage Warrants Issued June 2020	$9.10	35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$32.68	1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$30.02	243,303		2,616		2,616
Totals		1,737,347	$	25,056	$	25,056

Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability


Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%

Share Capital (Tables)

6 Months Ended

Jun. 30, 2024

Disclosure of Share Capital [Line Items]

Schedule of Common Stock Outstanding Roll Forward

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:


	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2024	209,871,792	38,531	216,690
Distribution of contingent consideration	1,250,000	—	—
Issuance of shares upon exercise of options	843,387	—	—
Issuances of shares upon vesting of RSUs	804,440	—	—
Repurchase of Subordinate Voting Shares	(2,725,000)	—	—
Exchange of shares	1,084,800	(848)	(10,000)
As at June 30, 2024	211,129,419	37,683	206,690

Share-based Payment Arrangement, Option, Activity

Stock option activity is summarized as follows:


	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life
Balance as of December 31, 2023	10,071,467	$11.75	4.31
Granted	797,289	14.96
Exercised	(843,387)	8.81
Forfeited	(828,488)	14.06
Balance as of June 30, 2024	9,196,881	$12.44	4.41
Exercisable as of June 30, 2024	4,214,462	$8.00	3.78

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions


	June 30,	December 31,
	2024	2023
Risk-free interest rate	3.25% - 3.92%	3.06% - 4.32%
Expected dividend yield	0%	0%
Expected volatility	62% - 64%	64%
Expected option life	4.46 - 4.5 years	3.5 – 4.5 years

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was as follows:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Stock options expense	$	2,637	$	4,303	$	5,694	$	8,786
Restricted Stock Units		6,229		3,078		9,662		4,834
Total Stock Based Compensation Expense	$	8,866	$	7,381	$	15,356	$	13,620

Restricted Stock Units

Disclosure of Share Capital [Line Items]

Non-vested Restricted Stock Shares Activity

The following table summarizes the number of unvested RSU awards as of June 30, 2024 and December 31, 2023 and the changes during the six months ended June 30, 2024:


	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2023	3,620,638	$	9.25
Granted	2,458,964		14.75
Forfeited	(609,639)		11.29
Vested	(804,440)		9.89
Unvested Shares at June 30, 2024	4,665,523	$	11.88

Income Tax Expense (Tables)

6 Months Ended

Jun. 30, 2024

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

The following table summarizes the Company’s income tax expense and effective tax rates for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
Income before Income Taxes	$	52,817	$	39,455	$	116,314	$	82,496
Income Tax Expense		31,899		25,765		64,048		59,401
Effective Tax Rate		60.4%		65.3%		55.1%		72.0%

Other Income (Expense) (Tables)

6 Months Ended

Jun. 30, 2024

Other Income and Expenses [Abstract]

Schedule of Other Nonoperating Income (Expense)

For the three and six months ended June 30, 2024 and 2023 other income (expense) was comprised of the following:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	(472)	$	(655)	$	167	$	(1,134)
Fair value adjustments on warrants issued		3,641		621		1,534		2,263
Loss from equity method investments		(772)		(432)		(1,100)		(750)
Other		67		196		100		275
Total Other Income (Expense)	$	2,464	$	(270)	$	701	$	654

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2024

Disclosure Text Block Supplement [Abstract]

Fair Value Measurements, Recurring and Nonrecurring

The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:


		As of June 30, 2024
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	196,142	$	—	$	—	$	196,142
Investments		24,695		—		36,717		61,412
Warrant Liability		—		—		(1,583)		(1,583)
	$	220,837	$	—	$	35,134	$	255,971


		As of December 31, 2023
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	161,634	$	—	$	—	$	161,634
Investments		24,215		—		40,146		64,361
Contingent Consideration Payable		—		—		(33,250)		(33,250)
Warrant Liability		—		—		(3,117)		(3,117)
	$	185,849	$	—	$	3,779	$	189,628

Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Schedule of Revenues

The below table presents revenues by type for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended June 30,				Six Months Ended June 30,
		2024		2023		2024		2023
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	204,656	$	188,044	$	408,434	$	376,922
Consumer Packaged Goods		156,323		136,054		306,235		261,671
Intersegment Eliminations		(80,832)		(71,710)		(158,716)		(137,669)
Total Revenues, Net of Discounts	$	280,147	$	252,388	$	555,953	$	500,924
Depreciation and Amortization
Retail	$	10,436	$	9,109	$	20,683	$	17,941
Consumer Packaged Goods		17,549		15,125		35,077		29,794
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	27,985	$	24,234	$	55,760	$	47,735
Income Taxes
Retail	$	16,405	$	13,328	$	33,969	$	32,339
Consumer Packaged Goods		15,494		12,437		30,079		27,062
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	31,899	$	25,765	$	64,048	$	59,401

Overview and Basis of Presentation - Additional Information (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Number of Shares Outstanding, Diluted	240,137,922	238,423,288	240,768,497	239,455,964
Anti-dilutive stock options excluded from the computation of diluted earnings per share	896,810	3,399,518	978,895	3,473,866
Employee Stock Option
Number of Shares Outstanding, Diluted			9,196,881	10,874,051
Weighted Average Number Diluted Shares Outstanding Adjustment	1,632,323	135,894	1,625,478	167,191
Restricted Stock Units
Number of Shares Outstanding, Diluted			4,665,523	3,453,460
Weighted Average Number Diluted Shares Outstanding Adjustment	971,792	287,259	1,939,848	1,587,917
Warrant
Number of Shares Outstanding, Diluted			2,128,022	3,734,555
Weighted Average Number Diluted Shares Outstanding Adjustment	117,434		119,259

Inventories - Summary of inventory (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Inventory [Line Items]
Raw Material	$ 2,205	$ 1,547
Packaging and Miscellaneous	11,021	10,661
Work in Process	51,219	47,029
Finished Goods	70,320	57,631
Reserve for Obsolete Inventory	(4,235)	(3,898)
Total Inventories, net	$ 130,530	$ 112,970

Property and Equipment - Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total Property and Equipment	$ 791,080	$ 757,529
Less: Accumulated Depreciation	(157,168)	(127,290)
Property and Equipment, net	633,912	630,239
Property and Equipment, net	694,039	687,106
Land [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	33,725	33,725
Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	1,168	1,046
Assets Under Construction [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	26,402	23,142
Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	354,195	353,912
Equipment, Computers and Furniture [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	182,041	171,522
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	222,073	200,232
Capitalized Interest [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	$ 31,603	$ 30,817

Property and Equipment - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of Property of Equipment [Line Items]
Depreciation expense	$ 15,412	$ 11,490	$ 30,516	$ 22,381
Cost of Sales [Member]
Disclosure of Property of Equipment [Line Items]
Depreciation expense	$ 9,930	$ 7,694	$ 19,723	$ 15,050

Intangible Assets And Goodwill - Summary Of Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 729,230	$ 729,230
Accumulated Amortization	215,796	190,552
Finite-Lived Intangible Assets, Net	513,434	538,678
Licenses And Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	660,716	660,716
Accumulated Amortization	179,813	157,764
Finite-Lived Intangible Assets, Net	480,903	502,952
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	41,511	41,511
Accumulated Amortization	14,746	13,378
Finite-Lived Intangible Assets, Net	26,765	28,133
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	24,438	24,438
Accumulated Amortization	18,672	16,927
Finite-Lived Intangible Assets, Net	5,766	7,511
Non Competition Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,565	2,565
Accumulated Amortization	2,565	2,483
Finite-Lived Intangible Assets, Net	$ 0	$ 82

Intangible Assets And Goodwill - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Amortization	$ 12,573	$ 12,744	$ 25,244	$ 25,354
Weighted average amortization period			10 years 10 months 28 days
Goodwill net of accumulated impairment losses	57,372		$ 57,372		$ 57,372
Goodwill impairment charge	0	$ 0	0	$ 0
Intangible assets [Member]
Goodwill net of accumulated impairment losses	$ 31,131		$ 31,131		$ 31,131

Intangible Assets And Goodwill - Summary Of Estimated Annual Amortization Expense Related To Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
Remainder of 2024	$ 25,148
2025	50,294
2026	47,332
2027	46,803
2028	46,803
2029 and Thereafter	297,054
Finite-Lived Intangible Assets, Net	$ 513,434	$ 538,678

Intangible Assets And Goodwill - Summary Of Goodwill And Intangible Assets Disclosure (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Goodwill [Line Items]
Goodwill	$ 589,691	$ 589,691
Retail Segment [Member]
Goodwill [Line Items]
Goodwill	273,802	273,802
Consumer Packaged Goods Segment [Member]
Goodwill [Line Items]
Goodwill	$ 315,889	$ 315,889

Investments - Schedule Of Long Term Investments (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Longterm Investments [Line Items]
Beginning balance	$ 64,361	$ 74,169
Additions	2,965	8,200
Disposals	(6,248)	(498)
Fair value adjustments	334	(17,460)
Transfers and other	0	(50)
Ending balance	$ 61,412	$ 64,361

Investments - Schedule of Change in Fair Value of Company's Investments (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Investments [Line Items]
Accrued Interest on Notes Receivable Instruments	$ 84	$ 78	$ 167	$ 206
Fair value (losses) gains	(388)	(577)	334	(928)
Equity Investments
Investments [Line Items]
Fair value (losses) gains	(481)	(655)	158	(1,134)
Notes
Investments [Line Items]
Fair value (losses) gains	$ 9	$ 0	$ 9	$ 0

Investments - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended
	Jan. 09, 2024	Apr. 30, 2021	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2019	Dec. 31, 2017
Investments [Line Items]
Unrealized gains and (losses) recognized on equity investments held			$ (253)	$ (653)	$ 319	$ 1,996
Fair value adjustments			9		9
Investment in non convertible instrument			24,188		24,188		$ 22,214
Debt instrument interest rate								7.00%	2.17%
Debt Maturity Date		Apr. 30, 2025
Accrued Interest on Notes Receivable Instruments			84	78	167	206
Cannabis Companies [Member]
Investments [Line Items]
Equity interest, fair value disclosure			61,412		61,412		64,361
Fair Value, Inputs, Level 1 [Member]
Investments [Line Items]
Equity interest, fair value disclosure			507		507		2,001
Proceeds from sale of equity interest in privately held entity					1,652	31
Fair value of losses on equity method of investment			(481)	655	158	1,134
Fair value adjustments on equity method investments				0		0
Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Equity interest, fair value disclosure			$ 25,953		$ 25,953		25,953
Notes Receivable [Member]
Investments [Line Items]
Accrued Interest on Notes Receivable Instruments	$ 605
Principal amount	$ 4,000
Notes Receivable [Member] \| Fair Value, Inputs, Level 1 [Member]
Investments [Line Items]
Debt instrument interest rate			13.00%		13.00%
Debt Maturity Date					Apr. 29, 2025
Notes Receivable [Member] \| Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Investment in non convertible instrument			$ 10,764		$ 10,764		$ 14,193
Accrued Interest on Notes Receivable Instruments			$ 84	$ 78	$ 167	$ 206
Minimum [Member] \| Notes Receivable [Member] \| Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Debt instrument, Term					12 months
Maximum [Member] \| Notes Receivable [Member] \| Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Debt instrument interest rate			10.00%		10.00%
Debt instrument, Term					5 years

Leases - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense	$ 12,425	$ 12,146	$ 24,676	$ 24,368
Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense	$ 166	$ 137	$ 305	$ 276
Maximum [Member] \| Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term	15 years		15 years
Minimum [Member] \| Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term	7 years		7 years

Leases - Schedule Of Other Information Related To Operating Leases (Detail)	Jun. 30, 2024	Dec. 31, 2023
Lessee, Lease, Description [Line Items]
Weighted average remaining lease term (years)	11 years 2 months 8 days	11 years 9 months
Weighted average discount rate	12.29%	12.40%

Leases - Lessee Operating Lease Liability Maturity (Detail) $ in Thousands	Jun. 30, 2024 USD ($)
Lessee, Lease, Description [Line Items]
Remainder of 2024	$ 22,918
2025	45,485
2026	45,705
2027	46,194
2028	45,262
2029 and Thereafter	331,258
Total Lease Payments	536,822
Less: Interest	(262,938)
Present Value of Lease Liability	273,884
Third Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2024	22,626
2025	44,893
2026	45,102
2027	45,622
2028	44,898
2029 and Thereafter	329,894
Total Lease Payments	533,035
Less: Interest	(261,707)
Present Value of Lease Liability	271,328
Related Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2024	292
2025	592
2026	603
2027	572
2028	364
2029 and Thereafter	1,364
Total Lease Payments	3,787
Less: Interest	(1,231)
Present Value of Lease Liability	$ 2,556

Notes Payable - Schedule of Debt (Detail) - USD ($)
$ in Thousands

Jun. 30, 2024

Dec. 31, 2023

Apr. 30, 2021

Debt Instrument [Line Items]

Total notes payable

$ 309,743

$ 308,523

Less: current portion of notes payable

(227,265)

(2,996)

Notes payable, net of current portion

82,478

305,527

Acquired Debt [member]

Debt Instrument [Line Items]

Total notes payable

^[1]

351

Private Placement Debt April 30, 2021 [Member]

Debt Instrument [Line Items]

Total notes payable

224,435

^[2]

221,680

^[2]

$ 224,435

Mortgage Notes [Member]

Debt Instrument [Line Items]

Total notes payable

^[3]

$ 85,260

$ 86,492

[1]	In connection with acquisitions completed in 2017 and 2019, the Company committed to provide charitable contributions of $50 thousand per quarter through October 2024 and $250 thousand per year through May 2024, respectively. The net present value of these contributions has been recorded as a liability with interest rates ranging between 2.17% - 7.00%
[2]	The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $249,934 thousand with an interest rate of 7%, maturing on April 30, 2025. The outstanding principal balance of the April 30, 2021 Notes was $224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $2,755 thousand as of December 31, 2023.
[3]	The Company has issued various mortgage notes at an aggregate value of $88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $671 thousand and $725 thousand, and are presented net of principal payments of $2,854 thousand and $1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00% and 7.77%.

Notes Payable - Schedule of Debt (Parenthetical) (Detail) - USD ($)
$ in Thousands

6 Months Ended

12 Months Ended

Apr. 30, 2021

Jun. 30, 2024

Dec. 31, 2023

Dec. 31, 2019

Dec. 31, 2017

Debt Instrument [Line Items]

Charitable Contribution Quarterly Payment

$ 250

$ 50

Charitable Contribution, Date Of Last Payment

May 2024

October 2024

Debt Instrument Interest Rate

7.00%

2.17%

Notes payable

$ 309,743

$ 308,523

Debt Maturity Date

Apr. 30, 2025

Private Placement Debt April 30, 2021 [Member]

Debt Instrument [Line Items]

Debt Instrument Interest Rate

7.00%

Notes payable

$ 224,435

224,435

^[1]

221,680

^[1]

Debt face value

$ 249,934

Debt Instrument Carrying Amount

2,755

Mortgage Notes [Member]

Debt Instrument [Line Items]

Notes payable

^[2]

85,260

86,492

Debt face value

88,785

Debt Instrument Carrying Amount

671

725

Debt Instrument, Annual Principal Payment

$ 2,854

$ 1,568

Mortgage Notes [Member] | Maximum [Member]

Debt Instrument [Line Items]

Debt Instrument Interest Rate

7.77%

Debt Maturity Date

Jun. 05, 2035

Mortgage Notes [Member] | Minimum [Member]

Debt Instrument [Line Items]

Debt Instrument Interest Rate

5.00%

Debt Maturity Date

Aug. 20, 2025

[1]

The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $249,934 thousand with an interest rate of 7%, maturing on April 30, 2025. The outstanding principal balance of the April 30, 2021 Notes was $224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $2,755 thousand as of December 31, 2023.

[2]

The Company has issued various mortgage notes at an aggregate value of $88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $671 thousand and $725 thousand, and are presented net of principal payments of $2,854 thousand and $1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00% and 7.77%.

Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Detail)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance \| shares	1,997,208
Number of Shares, Expired \| shares	(1,606,533)
Number of Shares, Ending Balance \| shares	390,675
Weighted Average Exercise Price, Beginning Balance \| $ / shares	$ 18.03
Weighted Average Exercise Price, Expired \| $ / shares	0
Weighted Average Exercise Price, Ending Balance \| $ / shares	$ 12.42
Weighted Average Contractual Life, Beginning Balance	6 months
Weighted Average Contractual Life, Ending Balance	5 months 15 days
Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance \| shares	1,737,347
Number of Shares, Expired \| shares	0
Number of Shares, Ending Balance \| shares	1,737,347
Weighted Average Exercise Price, Beginning Balance \| $ / shares	$ 31.83
Weighted Average Exercise Price, Expired \| $ / shares	0
Weighted Average Exercise Price, Ending Balance \| $ / shares	$ 31.83
Weighted Average Contractual Life, Beginning Balance	2 years 4 months 17 days
Weighted Average Contractual Life, Ending Balance	1 year 10 months 17 days

Warrants - Schedule Of Fair Value Of Warrant Liability (Detail) - Liability Classified Warrant [member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Jun. 30, 2024
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,997,208	390,675
Warrant Liability	$ 3,117	$ 1,583
Change in Fair value of warrants liability	(1,534)
Private Placement Financing Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price		$ 19.39
Warrants Outstanding		0
Warrant Liability	1,673	$ 0
Change in Fair value of warrants liability	(1,673)
Modification Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price		$ 12.04
Warrants Outstanding		316,947
Warrant Liability	1,151	$ 1,280
Change in Fair value of warrants liability	129
Additional Modification Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price		$ 14.03
Warrants Outstanding		73,728
Warrant Liability	293	$ 303
Change in Fair value of warrants liability	$ 10

Warrants - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Class of Warrant or Right [Line Items]
Fair Value Adjustment of Warrants	$ 3,641	$ 621	$ 1,534	$ 2,263

Warrants - Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability (Detail) - Liability Classified Warrant [member]	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Volatility \| Minimum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.7481	0.6176
Volatility \| Maximum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.7997	0.7431
Remaining Term \| Minimum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	4 months 9 days	4 months 20 days
Remaining Term \| Maximum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	10 months 20 days	1 year 4 months 20 days
Risk Free Rate \| Minimum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0402	0.0391

Warrants - Fair Value Of The Equity Classified Warrants (Detail) - Equity Classified Warrant [member] - USD ($) $ / shares in Units, $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,737,347	1,737,347
Warrant Liability	$ 25,056	$ 25,056
Dispensary Mortgage Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price	$ 9.1
Warrants Outstanding	35,000
Warrant Liability	$ 181	181
Private Placement Refinance Warrants April 2021 [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 32.68
Warrants Outstanding	1,459,044
Warrant Liability	$ 22,259	22,259
Private Placement Refinance Warrants October 2021 [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 30.02
Warrants Outstanding	243,303
Warrant Liability	$ 2,616	$ 2,616

Warrants - Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Equity Classified Warrants (Detail) - Equity Classified Warrant [Member]	6 Months Ended
	Jun. 30, 2024
Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Oct. 15, 2021
Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Apr. 30, 2021
Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Jun. 05, 2020
Volatility \| Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.73
Volatility \| Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.73
Volatility \| Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.80
Remaining Term \| Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	4 years
Remaining Term \| Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	4 years
Remaining Term \| Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	5 years
Risk Free Rate \| Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0112
Risk Free Rate \| Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0074
Risk Free Rate \| Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0037

Share Capital - Schedule of Common Stock Outstanding Roll Forward (Detail)	6 Months Ended
	Jun. 30, 2024 shares
Subordinate Voting Shares [Member]
Class of Stock [Line Items]
Beginning balance	209,871,792
Ending balance	211,129,419
Subordinate Voting Shares [Member] \| Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	209,871,792
Distribution of contingent consideration	1,250,000
Issuance of shares upon exercise of options	843,387
Issuances of shares upon vesting of RSUs	804,440
Repurchase of Subordinate Voting Shares	(2,725,000)
Exchange of shares	1,084,800
Ending balance	211,129,419
Multiple Voting Shares [Member]
Class of Stock [Line Items]
Beginning balance	38,531
Ending balance	37,683
Multiple Voting Shares [Member] \| Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	38,531
Exchange of shares	(848)
Ending balance	37,683
Super Voting Shares [Member]
Class of Stock [Line Items]
Beginning balance	216,690
Ending balance	206,690
Super Voting Shares [Member] \| Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	216,690
Exchange of shares	(10,000)
Ending balance	206,690

Share Capital - Share-based Payment Arrangement, Option, Activity (Detail) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Balance	10,071,467
Number of Share, Granted	797,289
Number of Shares, Exercised	(843,387)
Number of Shares, Forfeited	(828,488)
Number of Shares, Ending Balance	9,196,881	10,071,467
Number of Share, Exercisable	4,214,462
Weighted Average Exercise Price, Balance	$ 11.75
Weighted Average Exercise Price, Granted	14.96
Weighted Average Exercise Price, Exercised	8.81
Weighted Average Exercise Price, Forfeited	14.06
Weighted Average Exercise Price, Ending Balance	12.44	$ 11.75
Weighted Average Exercise Price, Exercisable	$ 8
Weighted Average Contractual Life, Balance	4 years 4 months 28 days	4 years 3 months 21 days
Weighted Average Contractual Life, Exercisable	3 years 9 months 10 days

Share Capital - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Risk-free interest rate, Minumum	3.25%	3.06%
Risk-free interest rate, Maximum	3.92%	4.32%
Expected dividend yield	0.00%	0.00%
Expected volatility	62.00%	64.00%
Minimum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected option life	4 years 5 months 15 days	3 years 6 months
Maximum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected volatility	64.00%
Expected option life	4 years 6 months	4 years 6 months

Share Capital - Non-vested Restricted Stock Shares Activity (Detail)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Balance \| shares	3,620,638
Number of Shares, Granted \| shares	2,458,964
Number of Shares, Forfeited \| shares	(609,639)
Number of Shares, Vested \| shares	(804,440)
Number of Shares, Balance \| shares	4,665,523
Weighted Average Grant Date Fair Value, Balance \| $ / shares	$ 9.25
Weighted Average Grant Date Fair Value, Granted \| $ / shares	14.75
Weighted Average Grant Date Fair Value, Forfeited \| $ / shares	11.29
Weighted Average Grant Date Fair Value, Vested \| $ / shares	9.89
Weighted Average Grant Date Fair Value, Balance \| $ / shares	$ 11.88

Share Capital - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 8,866	$ 7,381	$ 15,356	$ 13,620
Stock options expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	2,637	4,303	5,694	8,786
Restricted Stock Units
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 6,229	$ 3,078	$ 9,662	$ 4,834

Share Capital - Additional Information (Detail) $ / shares in Units, $ in Thousands				3 Months Ended		6 Months Ended
	Feb. 15, 2024 USD ($)	Feb. 09, 2024 shares	Jun. 01, 2018	Jun. 30, 2024 USD ($) shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Dispensary $ / shares shares	Jun. 30, 2023 USD ($)	Sep. 05, 2023 USD ($) shares
Selling, General and Administrative Expense				$ 96,500	$ 84,217	$ 170,758	$ 164,736
Dharma Pharmaceuticals LLC [Member]
Conversion of Stock, Shares Issued \| shares		1,250,000				65,000,000
Selling, General and Administrative Expense	$ 15,991
Dharma Pharmaceuticals LLC [Member] \| Maximum [Member]
Retail dispensary \| Dispensary						5
Restricted Stock Units (RSUs) [Member]
Cost Not yet Recognized, Amount				$ 63,591		$ 63,591
Cost Not yet Recognized, Period for Recognition						2 years 2 months 15 days
Multiple Voting Shares [Member] \| Conversion Of Multiple Voting Shares [member]
Voting Rights						100
Subordinate Voting Shares [Member] \| Dharma Pharmaceuticals LLC [Member]
Issuance of shares under business combinations and investments, value	$ 17,259
Subordinate Voting Shares [Member] \| GTII Stock and Incentive Plan [Member]
Percentage of maximum number of shares issued under the plan			10.00%
Super Voting Shares [Member] \| Conversion Of Super Voting Shares [member]
Voting Rights						1,000
Repurchase of Subordinate Voting Shares[Member]
Percentage of Stock Repurchase Program, Authorized								5.00%
Share Repurchase Program, Authorized, Number of Shares \| shares				2,725,000		2,725,000		10,486,951
Accelerated Share Repurchases, Final Price Paid Per Share \| $ / shares						$ 12.27
Share Repurchase Program, Remaining Authorized, Amount				$ 26,700		$ 26,700
Share Repurchase Program, Authorized, Amount								$ 50,000

Income Tax Expense - Schedule of Components of Income Tax Expense (Benefit) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Income before Income Taxes	$ 52,817	$ 39,455	$ 116,314	$ 82,496
Income Tax Expense	$ 31,899	$ 25,765	$ 64,048	$ 59,401
Effective Tax Rate	60.40%	65.30%	55.10%	72.00%

Income Tax Expense - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income tax paid	$ 52,904	$ 52,134

Other Income (Expense) - Schedule of Other Nonoperating Income (Expense) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Fair value adjustments on equity investments	$ (472)	$ (655)	$ 167	$ (1,134)
Fair value adjustment on warrants issued	3,641	621	1,534	2,263
Loss from equity method investments	(772)	(432)	(1,100)	(750)
Other	67	196	100	275
Total Other Income (Expense)	$ 2,464	$ (270)	$ 701	$ 654

Commitments and Contingencies - Additional of Information (Detail) $ in Thousands	1 Months Ended	6 Months Ended	12 Months Ended
	Aug. 01, 2024 USD ($)	Jun. 30, 2024 USD ($) Lawsuit	Dec. 31, 2023 Lawsuit
Subsequent Event [Member]
Disclosure of Commitments and Contingencies [Line Items]
Loss contingency, damages sought, value	$ 7,307
Construction Commitments [Member]
Disclosure of Commitments and Contingencies [Line Items]
Contractual obligation		$ 5,400
Pending Litigation [Member]
Disclosure of Commitments and Contingencies [Line Items]
Loss contingency, number of plaintiffs \| Lawsuit		0	0

Fair Value Measurements - Fair Value Measurements, Recurring and Nonrecurring (Detail) - Financial Instruments [Member] - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	$ 196,142	$ 161,634
Investments	61,412	64,361
Contingent Consideration Payable		(33,250)
Warrant Liability	(1,583)	(3,117)
Fair Value, Net Asset (Liability)	255,971	189,628
Fair Value, Inputs, Level 1 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	196,142	161,634
Investments	24,695	24,215
Contingent Consideration Payable		0
Warrant Liability	0	0
Fair Value, Net Asset (Liability)	220,837	185,849
Fair Value, Inputs, Level 2 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments	0	0
Contingent Consideration Payable		0
Warrant Liability	0	0
Fair Value, Net Asset (Liability)	0	0
Fair Value, Inputs, Level 3 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments	36,717	40,146
Contingent Consideration Payable		(33,250)
Warrant Liability	(1,583)	(3,117)
Fair Value, Net Asset (Liability)	$ 35,134	$ 3,779

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Disclosure Text Block Supplement [Abstract]
Notes payable	$ 309,743	$ 308,523
Current Portion of Notes Payable	$ 227,265	$ 2,996

Segment Reporting - Schedule of Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Revenues	$ 280,147	$ 252,388	$ 555,953	$ 500,924
Depreciation and Amortization	27,985	24,234	55,760	47,735
Income Taxes	31,899	25,765	64,048	59,401
Operating Segments [Member] \| Consumer Packaged Goods Segment [Member]
Segment Reporting Information [Line Items]
Revenues	156,323	136,054	306,235	261,671
Depreciation and Amortization	17,549	15,125	35,077	29,794
Income Taxes	15,494	12,437	30,079	27,062
Operating Segments [Member] \| Retail Segment [Member]
Segment Reporting Information [Line Items]
Revenues	204,656	188,044	408,434	376,922
Depreciation and Amortization	10,436	9,109	20,683	17,941
Income Taxes	16,405	13,328	33,969	32,339
Operating Segments [Member] \| Intersegment Eliminations and Corporate [Member]
Segment Reporting Information [Line Items]
Revenues	(80,832)	(71,710)	(158,716)	(137,669)
Depreciation and Amortization	0	0	0	0
Income Taxes	$ 0	$ 0	$ 0	$ 0

Segment Reporting - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Goodwill	$ 589,691	$ 589,691
Intangible Assets Net	513,434	538,678
Consumer Packaged Goods Segment [Member]
Goodwill	315,889	315,889
Retail Segment [Member]
Goodwill	273,802	273,802
Operating Segments [Member] \| Consumer Packaged Goods Segment [Member]
Goodwill	315,889	315,889
Intangible Assets Net	247,011	260,186
Operating Segments [Member] \| Retail Segment [Member]
Goodwill	273,802	273,802
Intangible Assets Net	$ 266,423	$ 278,492

Green Thumb Industries (QX) (USOTC:GTBIF)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

Plus de graphiques de la Bourse Green Thumb Industries (QX)

Green Thumb Industries (QX) (USOTC:GTBIF)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GTBIF Green Thumb Industries Inc (QX)

Actualités Green Thumb Industries Inc (QX)

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GTBIF Green Thumb Industries Inc (QX)

Actualités Green Thumb Industries Inc (QX)

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

BLACK FRIDAY

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres